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Severe maternal morbidity (SMM) rates in Michigan have increased over the past 20 
years and continue to affect racial and ethnic women disproportionately. Women 
experiencing health conditions that complicate pregnancy outcomes have a greater risk of 
having poor obstetric outcomes that result in a SMM event. To evaluate the distribution 
of women experiencing health conditions that complicate pregnancy and a SMM event, 
geographic information systems were utilized in this study. The purpose of this study was 
to depict trends in the prevalence of 4 health conditions and SMM among women 
hospitalized for obstetric delivery in Michigan from 2016–2017. The 4 health conditions 
associated with pregnancy complications were obesity, hypertension, mental health 
diagnosis, and diabetes. This study was supported by the socio-ecological model and the 
critical race framework that advance the idea that an individual’s health is a consequence 
of the environment, structural and intrapersonal factors, and the community where they 
live and seek healthcare services. A retrospective cohort analysis was conducted using 
the 2016–2017 State Inpatient Database, which is the largest database for delivery 
hospitalizations with race and ethnicity included. Logistical regression analysis indicated 
an association with geographic location and race and ethnicity, which were the 
sociodemographic predictors related to SMM risk. The analysis provided detailed 
information on the locations with the greatest need for more comprehensive maternal 
health interventions. This study contributes to social change by focusing on improving 
the health of women, who are of childbearing age, through equitable interventions that 
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Section 1: Foundation of the Study and Literature Review  
Introduction 
Maternal health has become a prominent news story due to the recent increases in 
mortality and morbidity. The World Health Organization  estimated that over 300,000 
women died globally from pregnancy complications and that the worldwide maternal 
mortality rate has dropped 44% since 1990; yet, in the United States, the maternal 
mortality rate has increased during that time. The United States is 1 of 8 countries that 
has experienced an increase in maternal mortality, ranking at the bottom of all developed 
countries (Hirshberg & Srinivas, 2017; WHO, 2015b). Maternal mortality is the death of 
a woman within 1 year of the end of pregnancy related to pregnancy or pregnancy 
management, whereas morbidity is unexpected outcomes from labor and delivery 
complications that can result in consequences to a woman’s health (Centers for Disease 
Control and Prevention [CDC], 2017b). Maternal mortality rates proxy the quality and 
effectiveness of a nation’s healthcare overall, and upon further analysis brings to light 
disparities within the healthcare system.  
 In the United States, approximately 700 women die per year from pregnancy-
related complications, and approximately 60% of those deaths are preventable (Peterson 
et al., 2019). Maternal mortality rates hover between 21–22 deaths per 100,000 live births 
(Moaddab et al., 2018). In Michigan, approximately 90 women die each year during the 
antepartum, intrapartum, or postpartum periods, which translate to about 9 deaths per 
100,000 live births (Michigan Maternal Mortality Surveillance Program [MMMS], 2018). 
While this may be lower than the national rate, it has highlighted disparate outcomes for 
2 
 
racial and ethnic women (Michigan Department of Health and Human Services Division 
for Vital Records & Health Statistics, 2018). 
The most common cause of pregnancy-related deaths in Michigan is 
cardiomyopathy (21%), followed by infection/sepsis (14%; MMMS, 2018). Less 
common but significant causes of death include cardiovascular conditions, amniotic fluid 
embolism, hypertension, and other medical conditions (primarily due to chronic diseases, 
such as cancer, epilepsy, and diabetes; MMMS, 2018). The most common cause of 
pregnancy-associated, but not related (i.e., injury), deaths is accidental poisoning/drug 
overdose (45%; MMMS, 2018). Other common causes of death include motor vehicle 
accidents (23%), homicide (16%), and suicide (11%; MMMS, 2018). According to the 
Michigan Pregnancy Risk Monitoring System (PRAMS, 2017) and resident live birth 
files from the Division for Vital Records and Health Statistics, in 2017, 52.4% of women 
delivering an infant entered pregnancy overweight or obese. The racial and ethnic 
disparities seen nationally are also patterned and observed in Michigan. From 2011–
2015, Black women were 3 times more likely to die from pregnancy-related causes in 
Michigan (27.7 versus 8.1 per 100,000 live births, respectively; MMMS, 2018). For the 
same timeframe, Black women were twice as likely to die from pregnancy-associated, not 
pregnancy-related, causes compared to White women (MMMS, 2018).  
Maternal morbidity and mortality, as well as the accompanying unintended 
outcomes, have been steadily increasing, gaining global, national, and statewide 
attention. Maternal mortality and morbidity are representations of the nation’s overall 
health and well-being of its citizens. Providing adequate care to women and children can 
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indicate how a nation, state, or local community takes care of the population at large. 
Poor health outcomes and the associated complications have detrimental effects on the 
mother, infant, and families affected by maternal mortality and morbidity. While it is 
important to note that the increase in maternal mortality and morbidity is attributed to 
improved surveillance, it can be linked to increasing prevalence of obesity and chronic 
health conditions (MacDorman, Declercq, Cabral & Morton, 2016). The CDC (2017b) 
has documented other potential risk factors such as maternal age (i.e., > 35 years old); 
women living in medically underserved or rural areas; and cesarean delivery, which may 
affect women differently (Kilpatrick, Ecker, & American College of Obstetricians and 
Gynecologists, 2016). Moreover, significant racial and ethnic disparities exist, especially 
for non-Hispanic Black women, who are 3 to 4 times more likely to die from 
complications related to pregnancy when compared to non-Hispanic White women 
(Admon et al., 2018; Creanga, Syverson, Seed, & Callaghan, 2017).  
Maternal mortality, although catastrophic, affects fewer women in the United 
States than severe maternal morbidity (SMM). Maternal morbidity affects more than 
60,000 women annually in the United States and is associated with high costs and 
disability (Chen, Chauhan, & Blackwell, 2018; Silveira et al., 2016). Due to the higher 
frequency of morbidity, the analysis and review of SMM events have the potential to be 
more informative for policy and practice. SMM, which is based on a specific set of 
inclusion criteria outlined by the CDC (discussed later in the study), is defined by any 
health condition attributed to and/or complication of pregnancy and childbirth that has a 
negative impact on a woman’s well-being and functioning and is described per 10,000 
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delivery hospitalizations (CDC, 2017b; Chou et al., 2016). The effects of maternal 
morbidity have a negative impact on a women’s well-being, family function, and an 
infant’s trajectory, which highlights the need for a comprehensive evaluation of the 
maternal morbidity burden. In response to these increasing trends, the WHO created the 
Maternal Morbidity Working Group to craft standardized definitions and measurement 
criteria (Machiyama et al., 2017). The mission of this group is to shift the focus from 
maternal mortality and move upstream to focus on women surviving childbirth with a 
morbid event (WHO, 2015a). This shift emphasizes the need for more robust systemic 
changes that focus on the entire life course. Researchers continue to study the collective 
impact on women’s function postmaternal morbid event and, therefore, require better 
understanding and more innovative analysis (Silveira et al., 2016).  
The Michigan Mortality Surveillance Committee, which is the nation’s longest 
standing mortality surveillance committee, has identified priority areas for the reduction 
of maternal mortality and morbidity (MMMS, 2018). In 2018, the Committee identified 
access to care, prenatal care, mental health, and a healthy lifestyle as the leading priority 
areas (Michigan Department of Health and Human Services Division for Vital Records & 
Health Statistics, 2018). The identification of priority areas within women’s health during 
preconception, perinatal, and postpartum may vary geographically across the state. Due 
to the striking variation regarding population density and geography across the state of 
Michigan, the recommendations vary widely due to resources and availability (MMMS, 
2018). This became apparent when evaluating existing metrics, such as neonatal 
abstinence syndrome, resulting from increased opioid use during pregnancy, where 
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Michigan’s rural areas have been disproportionately affected by this epidemic (CMS, 
2019; Michigan Department of Health and Human Services Division for Vital Records & 
Health Statistics, 2018). Enhanced tracking of SMM is one way to identify priority areas 
for interventions, quality improvement, and effective interventions. This aligns with 
reports from the CDC; other state’s Maternal Mortality Review Committees; and the 
Preventing Maternal Deaths Act of 2018, which emphasizes the need for identification 
and analysis of maternal death and morbidity at the state level (CDC, 2016).  
Recently, national findings have associated the risk of SMM with geographic 
location, race and ethnicity, and chronic or preexisting health conditions (Admon et al., 
2018; CDC, 2016; Chen et al., 2018; Silveira et al., 2016; Somer, Sinkey, & Bryant, 
2017). Black women die from pregnancy-related causes at higher rates when compared to 
White women, which is reflected in Michigan’s SMM rates (MMMS, 2018; Petersen et 
al., 2019). Those disproportionate rates are aggravated when chronic conditions are added 
to the analysis and affect racial and ethnic women disproportionately (Admon et al., 
2018; Somer et al., 2017). Increasing rates of preexisting, chronic conditions within racial 
and ethnic women demonstrate inequitable care despite the advances in transportation, 
medical technologies, and health policy (Creanga et al., 2017; Louis, Menard & Gee, 
2015; Somer et al., 2017). Women living in rural communities have experienced greater 
rates of SMM, including higher rates of eclampsia (Lisonkova et al., 2016). Moreover, it 
is important to note that the effects of morbidity not only manifest in physical chronic 
conditions but as a mental and behavioral health risk. Machiyama et al. (2017) found 
SMM was associated with depression, diabetes, and incontinence among other burdens of 
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ill health, such as mental, social, economic, marital, and sexual functioning. Maternal 
depression and anxiety contribute to the rising numbers of maternal morbidity yet has 
been underreported and often overlooked in current literature. These disproportionate 
health outcomes have been associated with higher medical costs, extended hospital stays, 
and excess trauma for women and families (Chen et al., 2018; Silveira et al., 2016). 
Examining the impact of geographic location, race and ethnicity, and health conditions 
associated with pregnancy complications have on delivery hospitalization in Michigan 
will impact the lives of its residents and reduce the healthcare burden on providers and 
patients.  
Problem Statement 
While maternal mortality is a sentinel event, SMM affects more than 50,000 
women per year, which is 100 times more frequent than maternal mortality (CDC, 
2017b). SMM is the unexpected outcome(s) of a delivery hospitalization that has short- 
and/or long-term complications (CDC, 2017b). The rates of SMM have been steadily 
increasing in the United States and Michigan for women of color, women living in 
resource-poor communities, and women living with preexisting health conditions (CDC, 
2017b). The burden of maternal morbidity has been discussed as the bottom, larger, and 
more dangerous part of the public health issue with more complicated pathologies. In 
2017, the Michigan SMM rate among all hospital deliveries was 1.7 per 10,000 delivery 
hospitalizations and affected racial and ethnic populations disproportionately: 1.4 for 
non-Hispanic White women, 1.42 for Native American women, 1.55 for Hispanic 
women, Asian women 1.67, and 2.77 for African American women (Michigan Alliance 
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for Innovation on Maternal Health, 2019). The consequences of increasing SMM rates on 
a women’s health are wide-ranging and complex. Understanding the patterns by 
geographic locations, race and ethnicity, and health conditions associated with pregnancy 
complications are essential to reducing the burden of SMM.  
Michigan is divided into 10 prosperity regions consisting of 83 counties and more 
than 1,100 zip codes (PRAMS, 2017). There are gaps in understanding the variability 
between zip codes and adverse maternal health outcomes, specifically racial and ethnic 
women living with health conditions that complicate pregnancy. It is important for the 
development of zip code level interventions to promote optimal health for women. 
Reliable and up to date zip code level data are essential to monitor widening inequities to 
inform innovative policies and programs that halt the disparities and manage the increase 
morbidity burden. In an effort to provide more statewide information, the purpose of this 
study was to describe SMM by geographic location, racial and ethnic women, and health 
condition.  
Purpose of the Study 
The purpose of this exploratory, retrospective cohort study was to describe SMM 
disparities during delivery hospitalizations in Michigan from 2016–2017. The highest 
burden of SMM clusters where health systems are weakest, the environment is resource-
poor, and individuals are living in the most vulnerable communities; the burden 
disproportionately falls on the most vulnerable women (Graham et al., 2016). The high-
risk conditions are generally undiagnosed or mismanaged chronic conditions that 
contribute to poor obstetric conditions (CDC, 2016). The variation in the prevalence of 
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chronic conditions, by race and ethnicity, has not been comprehensively examined in a 
statewide sample of delivering women. The health disparities among racial and ethnic 
groups experiencing poorer health outcomes prompted a deeper analysis into the specific 
locations these events are occurring to provide access to adequate health care, 
contraception counseling, prenatal and postpartum care, and improvement in tailored 
public health interventions.  
In this study, I compared maternal morbidity among geographic location, race and 
ethnicity, and health conditions associated with pregnancy complications associated with 
SMM outcomes. Using ArcGIS software for geographic, spatial reference and analysis 
provided a better understanding where persistent maternal and pregnancy related health 
issues occur in Michigan. This approach was unique insofar as I described the 
characteristics of the population by (a) SMM, (b) geographic location, (c) race and 
ethnicity, and (d) health condition impacting pregnancy outcomes. Furthermore, the 
conditions associated with greater socioeconomic and health-access disparities were 
explicated.  
Makanga, Schuurman, von Dadelszen, and Firoz (2016) urged researchers to 
develop a spatial analysis that would inform the geographical variation in risk factors on 
adverse maternal outcomes to better inform practitioners. There is limited Geographic 
Information Systems (GIS) evidence that exists, and more explicit use of this technology 
can account for geographical variation in Michigan. The analysis promoted a call to 
action for those striving to improve access to healthcare services prior to delivery for 
women living in Michigan’s most vulnerable communities. This study provides an 
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opportunity for public health personnel to understand the health disparities in SMM rates, 
including preexisting conditions, preconception health, and access to women’s health 
services. The findings of this study may shed light on the geographic variation and 
disparities for women and provide a unique opportunity for improvement in coordinated 
services to manage chronic conditions prior to pregnancy.  
Currently, geographic disparities in SMM have not been adequately examined; for 
example, knowing where there are greater rates of obesity and a SMM event in a specific 
zip code will help prompt public health interventions to become more tailored, timely, 
and poignant. Addressing SMM after pregnancy is less timely and unlikely to have 
lasting effects; however, providing care for a preexisting medical condition prior to 
pregnancy and birth may become more sufficient in preventing an event, considering 
50% of pregnancies in the United States are unplanned (Metcalf, Wick, & Ronksley, 
2018). Depicting these rates will help notify public health professionals of the areas with 
the greatest need. The use of GIS to demonstrate geographic patterns through combining 
various individual level characteristics, indicators, and risk factors that may be associated 
with SMM can contribute to the identification of high priority areas that need robust 
maternal health services.  
Research Questions and Hypotheses 
The central research question guiding this study was: Are there differences in 
SMM rates among geographic location and racial/ethnic (i.e., non-Hispanic Black, 
Hispanic, Asian or Pacific Islander, and Native American or Alaska Native) women? 
RQ1: Are there geographic variations of SMM across the state of Michigan?  
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H01: There are no statistically significant geographic variations in the 
incidence of severe maternal morbidity across the state of Michigan.  
HA1: There are statistically significant geographic variations in the 
incidence of severe maternal morbidity across the state of Michigan by 
race and ethnicity.  
RQ2: Are there racial and ethnic variations of SMM across the state of Michigan?  
H02: There are no statistically significant racial and ethnic variations in the 
incidence of SMM across the state of Michigan.  
HA2: There are statistically significant racial and ethnic in the incidence of 
SMM across the state of Michigan by race and ethnicity.  
RQ3: Are there racial/ethnic variation between women who have a health chronic 
condition and SMM across the state of Michigan? 
H03: There are no statistically significant variations in the prevalence of 
a health condition that complicates pregnancy outcomes (i.e., preexisting 
diabetes, preexisting hypertension, obesity, mental health diagnosis, 
alcohol use during pregnancy, drug use during pregnancy, tobacco use 
during pregnancy, gestational diabetes, and gestational hypertension) 
across the state of Michigan by race and ethnicity.  
HA3: There are statistical significance in the prevalence of a health 
condition that complicates pregnancy outcomes (i.e., preexisting diabetes, 
preexisting hypertension, obesity, mental health diagnosis, alcohol use 
during pregnancy, drug use during pregnancy, tobacco use during 
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pregnancy, gestational diabetes, and gestational hypertension) across the 
state of Michigan by race and ethnicity.  
Theoretical Foundation 
For the theoretical framework of this study, I used the social-ecological model, 
developed in the 1980s by Urie Bronfenbrenner and the critical race theory developed by 
a group of researchers including Kimberle Crenshaw, Neil Gotanda, Gary Peller, Kendall 
Thomas, and Derrick Bell’s critical race theory and Arline Geronimus. The social-
ecological model introduced human development in the context of an entire ecological 
system (Bronfenbrenner, 1994). The socio-ecological model suggests that birth outcomes 
are impacted by the environment into which a child is born and is subsequently 
influenced by the community and society (Bronfenbrenner, 1994). Maternal and infant 
health has been studied in the context of the socio-ecological model to provide potential 
solutions for healthcare disparities. Additionally, the critical race theory conveyed how 
racism contributed to cultural perceptions and societal norms, as well as how that was 
represented in the criminal justice system, housing and employment opportunities, and 
how policies were enacted (Bell, 1995; Gotanda & Peller, 1995) 
Socioecological Model 
The ecological model posits that a public health program, such as one designed to 
address SMM, is the result of influences across all levels of the problem (Glanz, Rimer, 
& Viswanath, 2015). The two specific concepts demonstrated in this model are that 
individual behaviors are affected by the social environment and that the behaviors are 
molded to multiple levels of influence, including the microsystem, mesosystem, 
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exosystem, and macrosystem (Bronfenbrenner, 1994). These terms are more simply 
understood when expressed at the individual, interpersonal, organizational, community, 
and societal levels; the different levels represent a unique influence on the individual. 
Each individual has a unique experience situated within the insidious influences from 
policies and laws in addition to the different contexts between and within the levels of 
influence. An examination of these dynamic levels can provide more information on the 
lived experiences of women. This model can provide consideration for the broader 
environmental context where, when, and how childbearing women experience SMM. To 
do so requires acknowledgement of an individual’s family values, church, school, lived 
experiences and peer influences (i.e., microsystem); the community’s ambulatory health 
caresettings, hospitals, and social service offices (i.e., mesosystem); the society’s cultural 
values and norms (i.e., exosystemic); and historical events, such as slavery, segregation, 
and the attitudes and ideologies of the culture in power (i.e., macrosystemic). In 
summary, there are multiple, upstream contributing factors at the microsystem, 
mesosystem, exosystem, and macrosystem levels that must be considered in order to 
better understand an individual’s health outcomes, and for the purposes of this study, 
specifically that of SMM.  
Critical Race Theory 
In this research, I took into account the work of Kimberle Crenshaw, Neil 
Gotanda, Gary Peller, Kendall Thomas, and Derrick Bell’s critical race theory and Arline 
Geronimus’s theory of weathering (see Bell, 1995; Geronimus, 2001; Gotanda & Peller, 
1995). Geronimus (2001) coined the term weathering in Ethnicity & Disease, describing 
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how constant stressors from racism contribute to a premature biologic aging process and 
poor health outcomes. Weathering is an integral component of the higher SMM rates that 
disproportionately affect African American pregnancy-related complications, which is 
displayed in the higher mortality rates from chronic conditions that may contribute to 
maternal mortality and morbidity (CDC 2017b; Geronimus, 2001). The critical race 
theoretical framework examines race and racism to understand how victims of systematic 
racism are affected by cultural perceptions of race and how that effects their lived 
experiences and world views as well as how that is represented in the United States (Bell, 
1995; Gotanda & Peller, 1995). Health outcomes for racial and ethnic women have 
shown similar poor outcomes across income and education levels, suggesting that racism 
may contribute to the underlying health disparities; racism has created barriers and also 
impacted women’s access to quality healthcare (Admon et al., 2018; Alio et al., 2010; 
Howland et al., 2019; Tangel, White, Nachamie, & Pick, 2018).  
Utilizing critical race theory in this study helped provide a context for 
understanding health disparities in maternal morbidity. Bringing awareness to a public 
health issue within a health equity framework can make an impact on the complex and 
upstream factors. In order to provide and promote a more equitable impact on women and 
reduce SMM rates among racial and ethnic women. Incorporating health equity into all 
research will emphasize the impact systems have on individuals and start to shift the 
narrative away from individual blame and towards larger systemic responsibility that will 
improve every pregnant women’s healthcare quality. 
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Nature of the Study 
My main priority in this study was to document a population-level analysis of 
SMM within delivery hospitalizations in Michigan utilizing data from the 2016–2017 
Statewide Inpatient Databases (SID). Using an exploratory, retrospective cohort 
framework, I demonstrated geographic and racial/ethnic variance in SMM across the state 
of Michigan using demographic, procedural, and diagnosis information. In addition, an 
examination of health conditions associated with pregnancy complications was 
documented using GIS. The use of GIS software displayed where racial and ethnic 
women with SMM and health conditions associated with pregnancy complications reside 
to document where disparities persist. Overall, the findings of this study elucidate where 
women with health conditions have the highest rates of SMM to help inform public 
health decisions concerning targeted, condition-specific interventions and prevention 
programs.  
Secondary Data Types and Sources of Information 
The data for this study were retrieved from the Healthcare Cost and Utilization 
Project (HCUP) due to it being the largest, longitudinal hospital database in the United 
States, which is funded through the Agency for Healthcare Research and Quality 
(Healthcare Cost and Utilization Project, 2019). The SID database  the largest source of 
administrative data with race and ethnicity for pregnant women who deliver in a 
community hospital setting. In the data set, I identified women whose delivery occurred 
in a Michigan hospital in 2016 and 2017 and excluded deliveries with missing data. 
15 
 
SMM was the primary outcome for this study, which was identified using the CDC’s 
SMM indicators.  
The key outcome (i.e., dependent) variable was the SMM indicated by 
International Statistical Classification of Disease and Related Health Problems (ICD-10-
CM) codes. The 21 SMM indicators to identify SMM criteria were outlined by the CDC, 
2017b) and are the most common diagnosis codes associated with SMM, including acute 
myocardial infarction, aneurysm, acute renal failure, adult respiratory distress syndrome, 
amniotic fluid embolism, cardiac arrest/ventricular fibrillation, disseminated intravascular 
coagulation, eclampsia, health failure, puerperal cerebrovascular disorders, pulmonary 
edema, severe anesthesia complications, sepsis, shock, sickle cell disease with crisis, air 
and thrombotic embolism, blood products transfusion, hysterectomy, and temporary 
tracheostomy. The independent variables included four health conditions associated with 
pregnancy complications. Admon et al. (2017) identified the common health conditions 
associated with obstetric morbidity and mortality among women of childbearing age 
across socioeconomic predictors of obstetric outcomes. Taking into account these 
conditions and current literature reviews, the four health conditions analyzed in this study 
were diabetes; hypertension; obesity; and mental health which included alcohol use 
during pregnancy, drug use during pregnancy, and tobacco use during pregnancy. Health 
conditions codes were located in the SID database within the diagnosis upon hospital 




I systematically searched the literature in PubMed, SAGE Journals, Google 
Scholar, and ProQuest databases. Using vocabulary and terms combining maternal 
health, maternal morbidity, health conditions, chronic conditions, and spatial 
epidemiology are listed here. The keywords searched were maternal morbidity, maternal 
death, maternal mortality, Michigan, spatial epidemiology, geographic information 
system (GIS), obstetric chronic conditions, and multiple chronic conditions. Searches 
were conducted between January 1, 2019 and November 1, 2019, with a 10-year data 
restriction unless a seminal paper was identified.  
Literature Review 
Historically, maternal mortality has been a traditional sentinel event for 
monitoring maternal health; however, maternal morbidity occurs more frequently and 
requires a deeper understanding and a more specific analysis (American College of 
Obstetricians and Gynecologists, 2015; The Joint Commission, 2015). While maternal 
mortality is easier to identify (due to a sentinel event), maternal morbidity is more 
complicated because it is less clearly defined due to reporting, coding, and timing (Main 
et al., 2016). SMM is a patient safety concern defined as a life-threatening diagnosis or 
enduring a life-saving procedure during a delivery hospitalization (Admon et al., 2018; 
Callaghan, Creanga, & Kuklina, 2012). Callaghan et al. (2012) estimated that SMM 
during delivery and postpartum hospitalizations has increased by 75% and 114%, 
respectively, since the time period between 2008–2009. Moreover, maternal morbidity 
has been associated with high levels of preventability, which is fundamental for public 
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health practitioners (Kilpatrick et al., 2016). The high levels of preventability associated 
with maternal morbidity provide an opportunity to identify risk factors to improve the 
health of women and create social change and health policies. 
The Joint Commission recognized a maternal morbidity when a woman receives 4 
or more units of blood and/or an intensive care unit (ICU) admission; however, due to 
recent quality improvement efforts at the national level, this may continue to change in 
order to continue to have clarity and consistency in data reporting (Leonard, Main, Scott, 
Profit, & Carmichael, 2019; Machiyama et al., 2017). Characterizing SMM events by 
diagnostic, administrative, and outcome data determine if the morbidity was preventable 
or avoidable, which help systems change and prompt quality improvement within 
organizations and, in turn, can guide more strategic public health interventions 
(Kilpatrick et al., 2016). While there are nuances and complexities to maternal morbidity 
diagnosis and surveillance, it can provide insight into severe pregnancy and delivery 
complications because it pertains to upstream risk factors, access to quality care, and 
racial and ethnic disparities.  
SMM has been categorized by some institutions as a near miss for maternal 
mortality because without proper identification and treatment, the complications could 
result in a maternal death (Main et al., 2016). Tracking SMM is essential for resource 
allocation, identification of priorities for researchers and clinicians, and helps create 
policies and procedures that improve the quality of a woman’s life; therefore, focusing 
research efforts on SMM is an upstream entry point into, ultimately, decreasing the 
maternal mortality rates. The analysis and subsequent interventions for women who 
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experience SMM are important for preventing disease and injuries as well as improving 
healthcare delivery. The CDC (2017b) published 21 SMM indicators based on ICD-10-
CM that rely on diagnosis codes from administrative data sources. The identification of 
SMM in a data set is a combination of diagnostic codes for an outcome of delivery, the 
diagnosis-related group delivery codes, and procedure codes for delivery-related 
procedures (Kuklina et al., 2008). The most common diagnoses associated with SMM are 
blood transfusion, hysterectomy, temporary tracheostomy with and without ventilation, 
postpartum hemorrhage (PPH), hypertension, stroke, renal failure, sepsis, pulmonary 
distress, cardiac disease, and an ICU stay (CDC, 2017b; Creanga, Bateman, et al., 2014; 
Kilpatrick et al., 2016). According to the CDC (2017b), nine SMM indicators have 
increased by more than 50% since 2014, including blood transfusion (399%), acute 
myocardial infarction or aneurysm (300%), acute renal failure (300%), adult reparatory 
distress syndrome (205%), cardiac arrest (175%), shock (173%), ventilation (93%), 
sepsis (75%), and hysterectomy (55%).  
Severe Maternal Morbidity and Race/Ethnicity 
SMM has been documented in the literature as an increasing trend that poses 
concern and draws attention to a widening disparity gap. The Institute of Medicine 
defined racial and ethnic disparities in obstetric care by the quality of care and health 
outcomes between groups who have similar health insurance and access (Smedley, Stith, 
& Nelson, 2003). In the United States, racial disparities in obstetric outcomes have been 
documented from preterm delivery to life-long debilitating repercussions from 
postpartum events, such as hemorrhage, stroke, and hypertensive disorders (Admon et al., 
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2018). This information has been used to demonstrate disproportionate distribution across 
racial and ethnic groups, specifically Hispanic, Black, African-American, Native 
American or Alaska Native, and Asian Pacific Islanders (Admon et al., 2018; Creanga, 
Bateman, et al., 2014; Howell et al., 2017; Leonard, Main, Scott, et al., 2019; Metcalfe et 
al., 2018).  
Researchers have highlighted the racial disparities in SMM and demonstrated that 
non-Hispanic Black women have a 3–4 times higher risk of mortality and a 9 times 
higher risk of morbidity than non-Hispanic White women (Admon et al., 2018; Creanga, 
Berg, et al., 2014). The U.S. SMM rates for non-Hispanic White women are 139.2 per 
100,000, while the SMM rates for non-Hispanic Black women are 231.1 per 100,000 
delivery hospitalization (Admon et al., 2018). Admon et al. (2018) estimated that if racial 
and ethnic women experienced SMM at the same rate as non-Hispanic White women, 
there would be 8,102 fewer SMM cases per year, resulting in a 28% reduction in SMM 
cases nationwide. 
Grobman et al. (2015) evaluated the differences in severe PPH, peripartum 
infection, and severe perineal laceration and found that non-Hispanic White women were 
significantly less likely to experience PPH and perineal laceration than non-Hispanic 
Black, Hispanic, and Asian women. Bryant et al. (2012) found that Hispanic and 
Asian/Pacific Islander have greater risk factors for atonic PPH. Similarly, Leonard, Main, 
Scott, et al. (2019) linked birth certificates to delivery discharge records and found that 
SMM was highest in non-Hispanic, Black women and lowest in non-Hispanic White 
women. Compared with non-Hispanic, White women, non-Hispanic Black women have a 
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greater risk of infections, preterm labor, antepartum hemorrhage, and hypertensive 
complications (Cabacungan, Ngui, & McGinley, 2012). The prevalence of preexisting 
diabetes was highest among American Indian/Alaska Native women, and the highest 
rates of gestational diabetes was highest among non-Hispanic Asian women (Deputy, 
Kim, Corney, & Bullard, 2018). Moreover, Hispanics, Asian/Pacific Islanders, and 
Native Americans had a greater likelihood of infection, PPH, and gestational diabetes 
than non-Hispanic White women (Cabacungan et al., 2012). 
The racial and ethnic disparities in the prevalence of SMM associated with 
preexisting health conditions have been documented in the literature. Women with 
preexisting health diseases or those who develop a pregnancy-associated disease have 
increased significantly within non-Hispanic Black and Hispanic populations (Admon et 
al., 2018; Metcalfe et al., 2018). Racial and ethnic disparities intertwined with a complex 
history of chronic health conditions and disease progression demonstrate the disparate 
outcomes in SMM rates. Maternal comorbidities, such as obesity, hypertension, and 
diabetes, are more frequently identified in racial and ethnic women (Leonard, Main, & 
Carmichael, 2019; Leonard, Main, Scott, et al., 2019; Robbins et al., 2018). The increase 
in risk factors prior to pregnancy may contribute to the higher rates of SMM, specifically 
in racial and ethnic populations that may have previously been marginalized and lacked 
trust in the healthcare system. This reflects multiple levels of health disparities rooted in a 
complex history of segregation and unfair clinical trials and treatments (Kennedy, 
Mathis, & Woods, 2007). One key example was identified by the Institute of Medicine 
who reported that racial and ethnic women are less likely to receive medically indicated 
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procedures yet receive more procedures overall that have been shown to be less effective 
(Smedley et al., 2003). The persistent health disparities may be due to a delay in 
treatment due to distrust in the healthcare system from a history of slavery, segregation, 
racism, and the lack of cultural competence and compassion by some providers (Corbie-
Smith, Thomas, & George, 2002). In order to develop a meaningful analysis, health 
disparities were attended to in this SMM study.  
Severe Maternal Morbidity and Health Conditions  
Complications from preexisting health conditions account for one third of all 
maternal deaths (Admon et al., 2018). The emergence of pregnancy-related death due to 
cardiovascular disease, cardiomyopathy, and other chronic conditions has increased 
(Creanga, Bateman, et al., 2014). Similarly, maternal morbidity trends have increased 
across the United States, providing more information about women’s health prior to and 
during pregnancy (CDC, 2019). A woman’s health before pregnancy can impact the 
future health of mother and child. Admon et al. (2017) found that rates of women with a 
chronic condition delivering in a hospital have increased from 66.9 per 1,000 delivery (in 
2005–2006) to 91.8 per 1,000 (in 2013–2014).  
The CDC (2017a) reported that nearly half of women are overweight or obese 
before pregnancy, which has been associated with delivery complications and severe 
morbidity. The rate of obesity and diabetes have been greatest in Black women, and those 
rates have been on the rise for the past decade for Hispanic women (CDC, 2017a). 
Creanga, Bateman, et al.(2014) found that the presence of chronic heart disease, chronic 
renal disease, and chronic liver disease was associated with higher rates of severe 
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morbidity and that the presence of HIV/AIDS infection doubled the rates of severe 
morbidity. Deputy et al. (2018) found that diabetes prevalence increased an infant’s risk 
of congenital anomalies and still birth. Diabetes can have serious and long-term effects 
on overall health, and elevated blood sugar has been associated with severe 
complications, including perinatal loss, preeclampsia, and macrosomia (American 
Diabetes Association, 2019). Metcalf et al. (2018) established that that maternal mortality 
review committees report that women who have died during pregnancy had one or more 
poorly managed health conditions. Overall, SMM among women with chronic health 
conditions, specifically multiple chronic health conditions, were significantly higher than 
women without chronic conditions (Admon et al., 2017; Admon et al., 2018). It is 
important to note that some of the previously mentioned health conditions, such as 
obesity and heart disease, are preventable (CDC, 2017b).  
The SMM classifications have mainly focused on physical health outcomes; 
however, trauma from an obstetric emergency and poor mental health management can 
contribute to poor short- and long-term pregnancy outcomes. According to the Michigan 
PRAMS (2017), half of the women in Michigan reported feeling depressed before, 
during, or after their pregnancy. Among women, depression and anxiety are the leading 
pregnancy-related mental health conditions (Creanga, Berg, et al., 2014; Robbins et al., 
2018). Women living with depression are more likely to have a chronic medical condition 
and have an increased risk of substance abuse, domestic violence, and poor long-term 
health, impacting the mother and infant’s overall health (Chang, Tabet, Elder, Kiel, & 
Flick, 2016; Robbins et al., 2018). This is the most underreported aspect of SMM because 
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often times the morbidity occurs outside of the hospital walls (Main et al., 2016). Furuta, 
Sandall, and Bick (2012) found that women who experienced severe preeclampsia had a 
greater risk of posttraumatic stress disorder. Women living in areas with greater rates of 
violence are more likely to experience depression or anxiety, which disproportionally 
affects African American, Hispanic, and Native American women (Chang et al., 2016; 
Somer et al., 2017). Trauma and mental health are disease burdens that impact women 
and family’s mental health before, during, and after pregnancy (Chang, Tabet, Elder, 
Kiel, & Flick, 2016; Creanga, Berg, et al., 2014; Robbins et al., 2018). 
Severe Maternal Morbidity and Geographic Location 
 Individual’s health experiences can operate differently in different places (Ballas, 
Clarke, Franklin, & Newing, 2017). Health geographers have documented that health 
inequalities are a combination of individual characteristics and contextual effects, such as 
where an individual grew up and lived (MacQuillan, Curtis, Baker, & Paul, 2019;  
Detres, Lucio, & Vitucci, 2014). GIS can help define a study population by spatial 
variation in disease risk. Using geospatial maps to analyze spatial health patterns and the 
social determinants of risk to identify health related clusters can help distribute health 
care resources. GIS allows public health practitioners the opportunity to ascertain where 
characteristic of contextual effects contribute to disease or poor health outcomes.  
Geographic location is a contributing factor to how and where women receive 
services. Rural living leaves women with little to no choice where they receive services 
and large metropolitan areas can lack availability and accessibility. The ability to 
interpret geographic location, as it relates to healthcare availability and resources, is 
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limited. Using data visualization techniques provides neighborhoods, regional 
collaborative, policymakers, and clinicians with an evidence base for important public 
health programs and funding. Similar analysis have been conducted for income 
variations, deprivation, and social demographics to help assess coverage and the breadth 
of services in specific geographic locations, which can facilitate targeting public health 
services. GIS mapping is an imperative tool for researchers, public health practitioners, 
and policymakers that should be readily available to combat this public health crisis and 
improve health equity while eliminating health disparities.  
Geographic location has been documented as a predictor of overall health 
including access to quality care. Different population densities have been associated with 
an array of complex geographic challenges (Ballas, Clarke, Franklin, & Newing, 2017). 
For example, fewer than 50% of rural women have access to perinatal care within 30 
minutes to their home, which continues to worsen due to the closing of more than 100 
rural hospitals since 2010 (Centers for Medicare and Medicaid Services [CMS], 2019). 
These closures disproportionately affected low-income communities and racial and ethnic 
women living in resource poor areas; maternal deaths are more common in rural 
communities worldwide (Makanga, Schuurman, von Dadelszen, & Firoz (2016). The lack 
of accessible prenatal care contributes to the burden of disease and the high rates of 
maternal morbidity and mortality.  
Women living in rural areas have higher rates of eclampsia, obstetric embolism, 
and uterine rupture (Lisonkova et al., 2016). In response to the rural health burden, the 
Centers for Medicare & Medicaid (2019) published an Issue Brief prioritizing health 
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policy for rural maternal healthcare. Rurality may contribute to inadequate access to 
services, higher rates of poverty and social isolation, which may impact a woman’s 
experience during the perinatal periods. Women living in rural areas are more likely to 
experience domestic violence and substance use disorders (Bhandari et al, 2015). 
Similarly, Admon et al. (2017) found an increasing prevalence of chronic conditions and 
substance use disorders for women living in rural communities compared to those within 
an urban residence. These rural challenges persist in Michigan, where more than half of 
the zip codes have an urban designation (Ratcliffe, Burd, Holder, & Fields, 2016). These 
issues present a unique opportunity to demonstrate the need for GIS maps indicating 
where disparities persist. Maternity care providers in rural areas must be aware of the 
increased burden of disease and how this distresses rural Michigan women.  
GIS is most widely used as a visualization tool to explore inequalities of health 
care outcomes and is a powerful tool for identification of health care facilities and access 
to quality care. The understanding of geographical aspects of health and health care 
resources are imperative for health care provisions and location planning and decision 
support for allocation of services (Ballas et al., 2017). This detailed information equips 
professionals with the knowledge to integrate additional healthcare services to an area 
with health inequities. Utilizing GIS to evaluate health and health care from a 
geographical perspective will play a major role in evaluating Statewide healthcare policy.  
Definitions 
Disparities: reference a health outcome that disproportionately affects the racial 
and ethnic women (CDC, 2017).  
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Maternal Morbidity: is an overarching term that refers to any event that directly 
relates to pregnancy and childbirth or may be a result of sequalae from the unintended 
event (Mosley, Koblinsky, Reed, National Research Council, & Committee on 
Population, 2000).  
Maternal Mortality: is the death of a woman while pregnant or within a year of 
the end of pregnancy from any cause (CDC, 2019).  
Near miss: is an event that may have resulted in harm to a patient, but the event 
did not reach the patient partially due to timely interventions (American College of 
Obstetricians and Gynecologists, 2015). 
Preexisting Health Conditions: are the nine-health condition associated with 
obstetric complications including: preexisting diabetes, preexisting hypertension, obesity, 
mental health diagnosis, alcohol us during pregnancy, drug use during pregnancy, 
tobacco use during pregnancy, gestational diabetes, and gestational hypertension. 
Racial and ethnic women: include non-Hispanic Black, Hispanic, Asian or Pacific 
Islander, and Native American or Alaska Native (CDC, 2017). 
Severe Maternal Morbidity: is the unexpected outcomes of labor and delivery that 
result in significant consequences to a woman’s health defined by 21 indicators and is 
described in a rate per 10,000 delivery hospitalizations (CDC, 2017b).  
Sociodemographic: refers to the economic, geographic and social measures of an 
individual’s experience (CDC, 2017). 
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Social Determinants of Health Inequalities: is used to describe the environmental 
and societal conditions where individuals are born, live, age, work, grow and can drive 
health outcomes (Marmont, 2005).  
Spatial Epidemiology: is the field of health geography that focuses on the spatial 
distribution of health outcomes (Ostfeld, Glass & Keesing, 2005). 
Assumptions 
This study should be interpreted with the assumptions and nature of the data set 
and study design. First, there is a possibility that each hospital discharge record might not 
be unique, and that one woman could have delivered twice during the study period due to 
the de-identified data (Admon et al., 2018). Second, health conditions may contribute to 
complications during birth and may result in severe maternal morbidity, however, this 
may not be the case due to misdiagnosis or a lack of adequate code and could be 
associated with low specificity. Third, the claims-based dataset may not always generate 
a specific payment for a chronic condition, which may be associated with low sensitivity.  
Scope and Delimitations 
Each year more than 200 million women become pregnant and many women 
experience the burden of severe maternal morbidity, which suggests this maternal health 
issue is not a marginal issue. This study takes cross-sectional data, aggregates women 
into a cohort and performs an analysis that may underestimate the true SMM rates and 
decrease the external validity. The burden of SMM may pose a greater threat than 
previously indicated due to undocumented diagnosis, long term sequala of infection, and 
may under-reported calculations (Graham et al., 2016; Machiyama et al., 2017). The 
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CDC published 21 SMM diagnosis codes, however this is not inclusive of all morbid 
events. Main et al. (2016) recommends the inclusion of the CDC’s criteria, as well as 
including a prolonged postpartum length of stay, maternal ICU admission, and/or an 
administration of any blood product would be a more sufficient measure. Lazariu, 
Nguyen, McNutt, Jeffrey, & Kacica (2017) proposed expanding the CDC measure of 
severe maternal morbidity to include additional comorbidities and found 3% increase in 
the number of cases when compared with the CDC measure only. American College of 
Obstetricians and Gynecologist & Society for Maternal Fetal Medicine (2018) 
recommend including transfusion of four or more units of blood and an admission into an 
ICU where there has been a higher positive predictive value for identifying SMM. 
Expanding on the CDC’s measures may provide a more sensitive estimate of the disease 
burden and provide clarity to the severity of this public health problem. Finally, the lack 
of a concise definition among systems and organizations implies that adopting an existing 
screening criterion or creating a document that represents SMM is what most institutions 
must do in order to identify gaps in care for quality improvement (American College of 
Obstetricians and Gynecologist & Society for Maternal Fetal Medicine, 2018). 
Ultimately, the primary and secondary aims of this exploratory study are the description 
of health disparities across the state of Michigan. This study may be generalizable to the 
public due to the large sample size and may help foster more tailored interventions based 




The increasing rates of SMM, which disproportionately affect racial and ethnic 
women, demand a call to action. The data visualization techniques proposed will 
determine locations where clusters of women experience SMM. Mapping SMM rates and 
health conditions by race and ethnicity will indicate where higher rates of adverse 
outcomes occur in Michigan, providing a more granular perspective of the specific needs 
in those communities. Delivery complications and morbidity identification may provide 
indicators of quality of care and racial and ethnic disparities that would benefit from an 
upstream public health intervention. This analysis will help determine areas that would 
benefit from more robust public health initiatives and interventions. The opportunity to 
employ SMM analysis to depict where enhanced public health outreach could have the 
highest impact on women’s overall health and well-being is a significant driver for social 
change.  
Severe Maternal Morbidity as a Public Health Concern 
SMM is a public health problem affecting an estimate of more than 700 women 
per year and non-Hispanic Black women and American Indian/Alaska Native women 
experience the highest rates (42.8 and 32.5, respectively) (Peterson et a., 2019). 
Unexpected outcomes of labor and delivery affect women of color at 3.3 and 2.5 times 
higher for non-Hispanic Black, and American Indian/Alaska native, respectively, as the 
non-Hispanic White women rate (13.0) (Callaghan et al.,2012; Peterson et al., 2019). 
Racial and ethnic monitories suffer more complications, injuries and disabilities than 
their White counterpart, which are mostly preventable and often lead to poor maternal 
30 
 
and infant health outcomes. Overall, the burden of SMM disproportionately affects 
women of color, living with lower socioeconomic status, chronic conditions, and 
dwelling in rural areas (Admon et al., 2017; Leonard et al., 2019). This increasing trend 
coupled with unexpected outcomes during labor and delivery can have short- and long-
term effects on a woman’s health (CDC, 2017b).  
SMM is a public health concern that has been demonstrated among racial and 
ethnic women, chronic disease, rurality, and low socioeconomic status disparities. The 
disparities in SMM rates demonstrates a call to action for a deeper analysis. Utilizing 
spatial epidemiology to map the widening disparities affecting the childbearing 
population will better equip public health professionals’ interventions in appropriate zip 
codes. Public health agencies, clinicians, and nurses interact with women during the 
prenatal stage throughout the pregnancy and into the postpartum periods. Those 
interactions occur throughout a variety of clinical and public health services in 
ambulatory care settings, inpatient and outpatient settings, community programs, public 
health-funded programs, and home visiting programs. Services provided are usually 
within the zip code the woman resides, yet many clinicians and health care providers are 
unfamiliar or do not live within similar neighborhoods or zip codes. Thus, these health 
professionals may not be accustomed to the community characteristics, nuances, 
prominent social determinants of health that affect a woman and her perinatal health care 
needs (Suplee, Bloch, Hillier, & Herbert, 2018). 
The rise in community-engagement action initiatives in the public health arena 
has provided an opportunity for clinicians, public health and nursing to learn more about 
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the social environments and communities where families reside. GIS has gained 
momentum for enhancing data visualization that can be used to better understand zip 
code variations and neighborhood characteristics as it relates to the residents’ health. 
Mapping data can organize and easily depict community characteristics to inform 
clinicians of barriers and challenges the individuals they serve experience. In this study, 
public and clinical health care providers can focus on the high rates of health conditions 
and rates of SMM for ethnic women and how that relates to their service areas.  
Severe Maternal Morbidity and Geographic Information Systems (GIS) 
GIS is a spatial software tool that displays geographic data at a neighborhood, 
street, census or zip code level. GIS technology helps capture, analyze and visualize 
health related data. The commonly used GIS software called ArcGIS is used for creating 
maps openly on a web application to share geographic information. GIS has been used in 
public health fields to map disease, health care utilization, and aids in identification of 
community needs (Detres, Lucio, & Vitucci, 2014). Moreover, on January 12, 2015, the 
United States Agency for International Development met in Washington, DC to discuss 
global Maternal and Child Survival Programs. This meeting convened 25 global health 
organizations, government agencies, donors, and universities advocated for more 
equitable analysis for those living in rural and hard to reach populations. The 
recommendations placed a strong emphasis on the application of GIS for maternal and 
neonatal health data in an effort to reduce preventable maternal and newborn mortality 
(Molla et al., 2017). Molla et al. (2017) explained that the data visualization and 
geospatial analysis can address key challenges in poorly resourced areas. Not only can 
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geospatial analysis be helpful at a global level, but it can help communities identify 
health related areas including socio-demographic characteristics, health behaviors, health 
outcomes, and factors influence health (Detres, Lucio, & Vitucci, 2014). The use of maps 
can engage a wide array of stakeholders from community members to hospital systems 
and garner support in discussions about programs that affect an individual’s health 
outcomes. 
Stopka, Krawczyk, Gradziel, & Geraghty (2014) utilized geographic information 
systems and cluster analysis to identify locations where Special Supplemental Nutrition 
Program for Women, Infants, and Children (WIC) Program services were needed. The 
analysis demonstrated statistically significant clusters of WIC-eligible nonparticipants, 
which provided a unique approach to determine where public health outreach would help 
improve enrollment. MacQuillan, Curtis, Baker, & Paul (2019) identified subgroups of 
women with high rates of gestational diabetes mellitus using birth records and geospatial 
mapping. Salehi and Ahmadian (2017) mapped women’s access to hospitals, which 
provided a robust identification of high priority areas that needed more access to 
advanced maternity care. Innovative analysis that yield maps help identify health related 
and physical barriers that contribute to maternal morbidities such as the built 
environment, racial segregation, and insufficient housing (Bloch & Cordivano, 2016; 
Mehra, Boyd, & Ickovics, 2017). The geospatial maps may prompt locations for deeper 
qualitative analysis such as focus groups and structured interviews to understand the 
nuances of health behaviors in a specific community. Mapping can be a valuable tool in 
the synthesis, exchange, and application of community knowledge to stakeholders and 
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nontraditional partners such as housing and youth programming (Detres, Lucio, & 
Vitucci, 2014). GIS mapping can accelerate innovation related to health programming for 
women to prevent complications and SMM. The literature indicates a growing need in 
making GIS data available to the community stakeholders to empower them to use data in 
a way that would stratify health problems within an ecological context.  
The increasing SMM trends have affected the nation’s women, families, and 
infants and prompts a call for a more innovative analysis with open access to medical 
journals for public health personnel. The increased incidence of SMM, coupled with 
clearly demonstrated racial and ethnic disparities, indicates an exploration of where 
women are more likely to have a negative health outcome. Due to the disparate reporting 
techniques and urban and rural geographical distribution in Michigan, less is known 
about precursors to maternal morbidity by regional health disparities. Spatial 
epidemiological methods could provide an innovative means by which to quantify severe 
maternal morbidity and pregnancy related health conditions by race and ethnicity. In lieu 
of the typical numeric tables and graphs, geo-spatial representations of data can provide a 
simplified means by which public health concerns and interventions can be understood 
and utilized by those in the broader community.  
Conclusion 
One of the most influential outcomes reflective of a country’s overall health and 
well-being is its maternal and child health outcomes, specifically maternal and infant 
mortality. The United States is ranked in the bottom quartile for maternal morbidity and 
Michigan rates reflect those national trends. This ranking is due in large part to racial and 
34 
 
ethnic disparities and pre-existing health conditions. While mortality is the most tragic 
event, morbidity plays a close second. High rates of maternal morbidity reflect the gaps 
in the healthcare system that can be addressed to reduce the chance of mortality taking 
place. The causes of maternal morbidity are diverse, including multiple chronic 
conditions, demographic, epidemiological, socioeconomic, and system-level factors. 
Despite technological advancements these rates persist and have recently increased over 
the past decade.  
Healthy People 2020 declared the elimination of health disparities, an 
improvement in health equity and overall health for all groups (HealthyPeople.gov, 
2017). Researchers have established that racial and ethnic health disparities persist and 
are associated with living environments, poverty, unemployment, crime, and racial 
segregation (Somer et al., 2017). Yet, the identification of specific, demographic, 
socioeconomic, environmental and behavioral factors to explain racial and ethnic 
disparities as it relates to health outcomes has not demonstrated the type of success that 
Healthy People posed 10 years prior. Understanding the scope of social determinants of 
health that occur within zip code can better guide the development of feasible and 
relevant interventions to reduce rates of health conditions and racial and ethnic health 
disparities. The use of spatial epidemiology and geospatial mapping can demonstrate the 
areas in Michigan with a higher level of deprivation, which can prompt tailored and 
specific geographical interventions, which is outlined in the next section.  
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Section 2: Research Design and Data Collection 
Introduction 
The purpose of this exploratory study was to describe SMM disparities during 
delivery hospitalizations in Michigan from 2016–2017. I used an exploratory cohort 
design to demonstrate geographic and racial/ethnic variance in SMM across the state of 
Michigan using demographic, procedural, and diagnosis information. In addition, I 
documented an examination of health conditions associated with pregnancy 
complications using GIS. GIS software was used to display where racial and ethnic 
women with SMM and health conditions reside to document where disparities persist. 
Overall, the findings of this study elucidate where women with health conditions have the 
highest rates of SMM to help inform public health decisions concerning targeted, 
condition-specific interventions and prevention programs.  
Research Design and Rationale 
In this exploratory study, I pooled, cross-sectional, 2016–2017 data from the SID 
to create a retrospective cohort of delivery hospitalizations in Michigan. The cohort 
consisted of women who were admitted into a Michigan hospital between the years 
2016–2017. Obstetric deliveries were stratified out of the larger data set and utilized as 
the denominator for the analysis. The primary outcome was the number of women who 
experienced a SMM event out of all of the delivery hospitalizations in Michigan between 
2016–2017. The covariates controlled in the analysis included age, race/ethnicity, 
insurance, and geographic dwelling (i.e., location).  
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The dependent variable was SMM as it was defined by the CDC. The independent 
variables were the health conditions associated with pregnancy complications; diabetes; 
hypertension; obesity; and mental health, including alcohol use during pregnancy, drug 
use during pregnancy, and tobacco use during pregnancy. I identified these variables 
through all ICD-10-CM diagnostic codes in the discharge record (i.e, 1–30) that indicated 
conditions complicating the pregnancy, childbirth, and puerperium outlined in the O-
chapter codes. The O-chapter includes all codes related to the perinatal period. I chose to 
focus on these conditions rather than pregnancy-related conditions to better inform 
prevention and upstream interventions for the greatest impact on women and families in 
Michigan. Admon et al. (2018) posited that there is a lack of information on the 
prevalence of health conditions by socioeconomic predictors, geographic location, 
income, and insurance status. The understanding of the prevalence of health conditions 
and its association with SMM is essential for healthcare providers, policy makers, and 
public health professions to identify populations that would benefit from evidence-based 
interventions to reduce the rates of maternal morbidity and the inequitable health 
outcomes for racial and ethnic women.  
Currently, most analyses conclude with tables and graphics that show which 
variables are statically significant. In this study, I took the analysis a step forward and 
mapped the significant existing health conditions by race and ethnicity to depict the 
communities with the greatest need to inform where targeted interventions and more 
resources are needed. For the purposes of this study, the data were used to depict health 
outcomes for racial and ethnic women by geographic location. Current research has 
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underutilized geospatial epidemiology to display areas of highest need. The practical 
application of GIS provides the capacity to identify where there are high priority 
communities, significant health disparities, and poorer health outcomes (Salehi & 
Ahmadian, 2017). These geographic characteristics helped provide context for the social 
determinants of health, including rural or urban dwellings, to provide a fundamental 
understanding of the communities with the greatest disparities. Finally, through this 
analysis, I provided critical emphasis on racial disparities, which may impact resource 
allocation for equitable perinatal healthcare.  
Methodology 
Population 
I performed the retrospective, pooled, cross-sectional analysis on a sample of all 
delivery hospitalization discharges in Michigan between 2016-2017 using the HCUP in 
the SID. The total number of hospitalizations accounted for in the SID in Michigan for 
2016–2017 was over 2.4 million; HCUP (2019) houses the largest nationally 
representative sample of hospital discharges in the United States. The SID contains 
discharges from 97% of all U.S. community hospital discharges that includes discharges 
from specialist facilities (HCUP, 2019). This database contains a set of clinical and 
nonclinical information and includes uninsured individuals. Data for each hospitalization 
includes diagnostic and procedure codes, patient demographic characteristics, insurance 
status, and information pertaining to the individual’s zip code.  
The study population included delivery hospitalizations from 2016–2017 in 
Michigan. I identified deliveries by ICD-10-CM codes by converting Kuklina et al.’s 
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(2008) enhanced method for identifying obstetric deliveries to the updated ICD-10 codes. 
The updated list of obstetric deliveries included Z37 Outcome of delivery diagnosis 
related group(DRG 767,768,774,775, 795, 797,798, 805, 806, 807, 951), O80 (DRG 998) 
encounter for full-term uncomplicated delivery, O82 (DRG 998) encounter for cesarean 
delivery without indication, and excluded O00–O08 ICD-10 codes for pregnancy with 
abortive outcomes.  
Sampling Procedure 
Gaining access to the SID required a Data Use Agreement Training Course and 
signed HCUP Data Use Agreement before the data were sent. After the completion of the 
training course, the SID required me to provide a Statement of Intended Use, which was 
sent to the HCUP Central Distributor and reviewed for approval by the AHRQ team. 
Upon receiving approval, the SID sent me the requested data, via U.S. Postal Services, on 
a CD-ROM, which was transferred into the Statistical Package for the Social Sciences 
(SPSS), Version 25 software. SPSS was used to calculate the sample size in order to test 
the research questions and hypotheses of the study. All delivery hospitalizations that fit 
the inclusion criteria were utilized. 
The identification of SMM as the primary outcome helped test the first 
hypothesis. SMM events were identified during delivery hospitalizations using an 
algorithm developed by the CDC that uses hospital discharge data, diagnosis, and 
procedure codes (i.e., ICD-10 Codes). The original list of SMM indicators was developed 
utilizing ICD-9 codes; however, the United States transitioned to the 10th Revision of 
ICD codes in October 2015 (CDC, 2017b). The CDC, along with their clinical and public 
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health partners, took into account prior validated studies to review this new set of 
indicators; Main et al. (2016) found that the previous SMM algorithm had 77% 
sensitivity, which was then adapted for ICD-10 coding and this set of indicators.  
To identify delivery hospitalizations with SMM in 2016–2017, I used the ICD-10 
codes. These codes include 21 indicators of SMM that represent serious complications 
during the hospital stay, such as eclampsia and health failure, as well as lifesaving 
procedures to manage serious health conditions, such as blood transfusions (CDC, 
2017b). The ICD-10 codes associated with SMM were indicated in the discharge field in 
the data set. A delivery hospitalization was included in the study population if any of the 
21 indicators were present on the discharge summary; the complete list of codes is 
available in Appendix A. I identified women with a health condition by searching all 
ICD-10-CM diagnostic codes associated with pregnancy complications. The list of 
preexisting chronic conditions along with the ICD-10 code is publicily available 













Health Conditions ICD 10-CM Codes 
Pregnancy Related Health Condition Type ICD-10-CM Code 
Diabetes Preexisting diabetes Codes within O24.3 
Gestational diabetes Codes within O24.410 
Hypertension Preexisting hypertension Codes within O10 and O11 
Gestational hypertension Codes within O10 and O11 
Obesity Obesity Codes within O99.210 
Mental health diagnoses Mental health diagnoses Codes within O99.340 
Alcohol use during pregnancy Codes within O99.310 
Drug use during pregnancy Codes within O99.320 
Tobacco use during pregnancy Codes within O99.330 
Imputing the data from the aforementioned analysis into ArcGIS, I analyzed racial 
and ethnic women who experienced preexisting health conditions and a SMM event. The 
unit of analysis was the patient’s zip code. Location of residence was defined by the 
National Center for Health Statistics’ (2017) Classification and Urban Influence Codes 
into four categories: large metro, medium metro, small metro, and micropolitan/urban. 
The graphical display for the third aim of my study helped fulfill the practical application 
of this research and inform policies for social change. 
I used these variables to answer the research questions, along with avoiding Type 
II errors (probability = β) related to the power of the test. Using G*Power 3 (Version 
3.1.9.4), a power analysis was conducted to determine the sample size and strength of the 
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power of the significance among the variables. Due to the large sample size (i.e., over 2.4 
million records between 2016–2017), the input parameters for the a priori power analysis 
were set to an effect size of .80, alpha level of .05, power of .95, odds ratio of 1.2, and a 
two-tailed test (see Faul, Erdfelder, Buchner, & Lang, 2013; Field, 2013). G*Power 
generates a sample size for the logistic regression analysis that was utilized to address the 
research questions. Based on the assumptions listed previously, the desired sample size 
was 2,451 cases (see Faul et al., 2013).  
Instrumentation and Operationalization of Constructs  
I conducted the descriptive statistics, chi-square, and univariate logistic regression 
analysis SPSS, Version 25 (see IBM Corp, 2017). The zip code data were analyzed 
utilizing GIS to display data geographically. The robust software utilized to depict 
epidemiological trends was created by the Environmental Systems Research Institute 
(2019), and I used the ArcGIS Desktop: Release 10.7.1 Version. This tool was used to 
visualize and analyze spatial relationships by importing and aggregating data. In this 
exploratory study, I demonstrated salient variation between geography and depicted 
where health disparities occur as well as clusters of highly vulnerable communities 
persist. The initial descriptive and inferential statistics helped address the three research 
questions. The GIS analysis generated maps that show SMM by racial and ethnic women 
who experienced obesity, diabetes, mental health diagnosis, or hypertension.  
Data Analysis Plan  
I used the cross-sectional SID to extract all delivery hospitalizations during the 
study timeframe. The data were pooled into a 2-year time period to increase the sample 
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size and precision of the analysis. The sampling strategy included the identification of all 
hospital deliveries occurring between 2016–2017 using an adaptation of Kuklina et al.’s 
(2008) standard methods. The first step was to identify the cohort of women who had a 
SMM outcome, and the second step was to identify women who experienced SMM and 
had one or more health chronic conditions associated with pregnancy complications (see 
Table 1). The data sets included deliveries occurring among non-Hispanic White, 
Hispanic, non-Hispanic Black, Asian or Pacific Island; and Native American women. 
Other variables of interest were age, location, race/ethnicity, and insurance.  
The categorization of variables was performed utilizing previous literature 
reviews. Payment sources were grouped into Medicaid and other. Age was categorized 
into three distinct subgroups reflecting the study populations (i.e., younger than 19, 19-
34, 35 and older). Race was categorized into three groups Black (non-Hispanic Black), 
White (non-Hispanic White), and other (Hispanic, Asian or Pacific Islander, and Native 
American or Alaska Native). Geographic location was divided into four meaningful 
groups that reflect Michigan’s population, which include large metropolitan, small 
metropolitan, micropolitan, and not metropolitan or micropolitan (National Center for 
Health Statistics, 2017). Any duplicate cases were excluded from the data, only complete 
cases were analyzed.  
The central research question guiding this study was: Are there differences in 
SMM rates among geographic location and racial/ethnic (i.e., non-Hispanic Black, 
Hispanic, Asian or Pacific Islander, and Native American or Alaska Native) women? 
RQ1: Are there geographic variations of SMM across the state of Michigan?  
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H01: There are no statistically significant geographic variations in the 
incidence of severe maternal morbidity across the state of Michigan.  
HA1: There are statistically significant geographic variations in the 
incidence of severe maternal morbidity across the state of Michigan by 
race and ethnicity.  
RQ2: Are there racial and ethnic variations of SMM across the state of Michigan?  
H02: There are no statistically significant racial and ethnic variations in the 
incidence of SMM across the state of Michigan.  
HA2: There are statistically significant racial and ethnic in the incidence of 
SMM across the state of Michigan by race and ethnicity.  
RQ3: Are there racial/ethnic variation between women who have a health chronic 
condition and SMM across the state of Michigan? 
H03: There are no statistically significant variations in the prevalence of 
a health condition that complicates pregnancy outcomes (i.e., preexisting 
diabetes, preexisting hypertension, obesity, mental health diagnosis, 
alcohol use during pregnancy, drug use during pregnancy, tobacco use 
during pregnancy, gestational diabetes, and gestational hypertension) 
across the state of Michigan by race and ethnicity.  
HA3: There are statistical significance in the prevalence of a health 
condition that complicates pregnancy outcomes (i.e., preexisting diabetes, 
preexisting hypertension, obesity, mental health diagnosis, alcohol use 
during pregnancy, drug use during pregnancy, tobacco use during 
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pregnancy, gestational diabetes, and gestational hypertension) across the 
state of Michigan by race and ethnicity.  
Characteristics of the Study Population 
The total population of 2016-2017 hospital deliveries from the SID was used to 
demonstrate descriptive statistics for deliveries by maternal characteristics age, race, 
insurance type, and geographic location, as well as health conditions associated with a 
pregnancy complication. The demographics tables show the percent of delivery 
hospitalizations for each sociodemographic characteristic of the mother (age, race, 
insurance, geographic location), and well as the percent of women in each category 
demonstrates the relative number of delivery hospitalizations for each demographic 
variable. The characteristics of the population are also detailed by the percent of delivery 
hospitalization with a health condition known to complicate pregnancy (diabetes, 
hypertension, obesity, and mental health conditions) from 2016-2017. These descriptive 
analyses help frame subsequent work for the severe maternal morbidity analysis. 
Chi-Square Analysis 
 In total, 21 indicators were used to demonstrate the incidence of Severe Maternal 
Morbidity in the total population of 2016-2017 hospital deliveries. The data were entered 
into IBM SPSS Statistics Version 25 and analyzed using chi-square tests (IBM Corp, 
2017). Utilizing SPSS and testing each covariate separately, a simple chi-square 
contingency table indicated that all sociodemographic variables were significant at the p 
= 0.05 level. The sociodemographic variables and the percent of deliveries with SMM, as 
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well as the percent of deliveries with a SMM event were used to find statistical 
significance.  
The second analysis tested whether diabetes, mental health, hypertension or 
obesity was significantly significant with a SMM diagnosis, independently. Each health 
conditions was analyzed independently with 95% CI. This represents the percent of 
deliveries with SMM, according to health conditions of the mother. I tested for 
significance at the .05 level to indicate which health conditions indicators were 
statistically significant.  
Logistic Regression 
I analyzed the health conditions and the sociodemographic indicators for an 
adjusted odds ratio (OR) associated with severe maternal morbidity, 2016-2017. To 
compare women with health conditions, I performed two logistic regression models. The 
partial logistic regression model included only sociodemographic variables and the 
second full logistic regression model included sociodemographic variables and health 
conditions. Both models were tested for an OR with a 95% confidence interval and lower 
and upper bounds. The procedure was based on Wald statistics produced significant 
variables.  
Geospatial Analysis 
The final analysis was entered into ArcGIS to demonstrate where racial and ethnic 
women who experienced a health condition and an SMM event were located. The unit of 
analysis was zip code; each zip code was coded large metro, medium-small metro, 
micropolitan/urban. The figures depict women who had any SMM event and a health 
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condition that complicated pregnancy to portray the most vulnerable population. The 
prevalence of these health conditions associated with obstetric morbidity are diabetes, 
hypertension, obesity, and mental health diagnosis. This highlights where women living 
with the highest risks and who could benefit from community public health efforts to 
ameliorate the deleterious effects of these compound problems.  
Threats of Validity 
Statewide administrative data is validated before final submission into the HCUP 
however, these diagnosis and procedure codes do not provide information on prenatal 
care, the severity of a condition or follow-up outside of the hospital setting. The cross-
sectional nature of the data limits our knowledge of whether the conditions have changed 
over time or led to mortality. Moreover, this analysis only accounted for the CDC’s 
definition of severe maternal morbidity, which includes 21 indicators that correspond 
with ICD-10 codes identified only during the hospitalization of record. The indicators do 
not specify length of stay or units of blood transfused during the delivery hospitalization, 
which might impact the level of morbidity.  
Ethical Procedures 
Regarding ethical considerations, the patient’s information was deidentified and 
remained confidential. Ethical approval was received from Walden University with the 
International Review Board (IRB) Approval Number 01-03-20-0667638.  
Summary 
The analysis of SMM for maternal demographics and maternal health conditions 
demonstrates the distribution for all delivery hospitalizations from 2016-2017 in 
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Michigan. The significant predictors of SMM for the maternal characteristics were age, 
race, location, and Medicaid insurance. For this analysis, the health conditions associated 
with SMM were hypertension, obesity, diabetes, and a mental health diagnosis. The 
logistic regression model will demonstrate differences between races, location, insurance, 
and health conditions. The GIS analysis depicts SMM rates with either obesity, 
hypertension, mental health diagnosis, or diabetes. This analysis will show the 
geographic variation of maternal health outcomes across the state of Michigan. Finally, 
this contribution will further the knowledge on health inequities to inform public health 
professionals residing in those communities to improve preventative programs, health 
access, and eliminate health disparities within the results section. 
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Section 3: Presentation of the Results and Findings 
Introduction 
Increasing rates of maternal mortality and morbidity are well documented in the 
United States, but there is limited state-specific documentation of disparities. Disparities 
in complications from pregnancy-related health conditions are the leading causes of 
maternal mortality and morbidity in the United States and similar issues occur in 
Michigan (Michigan Maternal Mortality Surveillance Program, 2018). State-level 
analysis can identify risk for delivery-related morbidity among women with health 
conditions, including those with diabetes, hypertension, mental health diagnosis, and 
obesity. The prevalence of those four conditions has increased over time; yet, less is 
known about the prevalence of the aforementioned conditions and SMM. It is unclear 
whether the prevalence of these conditions are associated with an SMM event and if the 
rates have stabilized, decreased, or worsened in recent years. Moreover, it is unclear how 
the prevalence of these conditions varies by patient’s location. This information is 
necessary for healthcare providers and policy makers to identify populations that would 
benefit from evidence-based interventions to reduce maternal morbidity in Michigan.  
To address these gaps in knowledge, the objective of this study was to estimate 
2016–2017 trends in the prevalence of conditions that may exacerbate SMM among 
delivery hospitalizations in Michigan. This included evaluating SMM and women who 
have experienced a health condition that may exacerbate her condition during pregnancy. 
The health conditions associated with pregnancy include hypertension, diabetes, obesity, 
and mental health diagnosis, which are generally undiagnosed (i.e., mental health) or 
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mismanaged conditions that contribute to poor obstetric conditions. The purpose of this 
analysis was to convey the prevalence of health conditions by geographic location that 
have not been comprehensively examined in a statewide sample of delivering women. 
Additionally, depicting those disparities by race and ethnicity may help clinicians provide 
adequate and culturally competent care to women with 1 of the 4 conditions. The rates of 
maternal morbidity and the association with health inequities by race and ethnicity for 
women experiencing SMM provided rationale for geospatial analysis to more accurately 
pinpoint where disparities exist. The final geospatial mapping depicted the geographic 
areas of women experiencing a SMM event and 1 of the 4 health conditions in order to 
provide healthcare professionals the information they need to improve maternal health 
outcomes.  
In this study, I provided analysis of SMM among geographic location, race and 
ethnicity, and the four health conditions, using ArcGIS software spatial reference and 
analysis to present geographical awareness to this persistent problem. In this study, I 
describe (a) SMM in Michigan from 2016–2017, (b) depict the geographic locations 
where women experience SMM who present with a health condition affecting pregnancy, 
and (c) examine the differences between race and ethnicity and SMM.  
The overarching research question was: Are there differences in SMM rates 
among geographic location and racial/ethnic (i.e., non-Hispanic black, Hispanic, Asian or 
Pacific Islander, and Native American or Alaska Native) women. The specific research 
questions addressed in this study were:  
RQ1: Are there geographic variations of SMM across the state of Michigan?  
50 
 
RQ2: Are there racial and ethnic variations of SMM across the state of Michigan?  
RQ3: Are there racial/ethnic variations between women who have 1 of the 4 
health conditions and SMM across the state of Michigan? 
The results section includes the findings and how the secondary data were 
collected. In this section, I report on baseline descriptive, demographic characteristics, 
population, and univariate analysis. The results also include statistical assumptions, 
statistical analysis, findings, and summary. The data are displayed using tables, graphs, 
and maps because they are appropriate for the study design.  
Data Collection of Secondary Data Set 
Using the SID to conduct this analysis, I extracted all delivery hospitalization 
discharges in Michigan from 2016–2017, which included 94% of all Michigan hospitals, 
and totaling 2,474,118 hospital discharges. The SID is the largest nationally represented 
state sample of hospital discharges in the United States. Each hospitalization 
encompasses clinical and nonclinical data, including diagnosis and procedure codes, 
payment source, patient and hospital location, and patient demographic variables that 
include race and ethnicity (HCUP, 2019). I identified 202,514 delivery hospitalizations in 
Michigan from 2016–2017. Deliveries were identified using the ICD-10-CM codes 
provided by the Michigan Department of Health and Human Services. The data were 
cleaned to include delivery hospitalizations with a race/ethnicity indicator; abortion, 




In order to construct the SMM data set, I utilized the CDC’s SMM ICD-10 codes, 
diagnosis codes (i.e., 1–30), and procedure codes (i.e., 1–15). I identified 2,460 SMM 
events between 2016–2017 in the data. Next, the prevalence of diabetes (i.e., preexisting 
and gestational); hypertension (i.e., preexisting and gestational); obesity (i.e., a body 
mass index >30); and mental health conditions that were associated with pregnancy, 
including tobacco, drug, and alcohol use. Each delivery hospitalization was flagged for 
one or more of the health condition diagnosis codes. If the delivery hospitalization did 
not indicate a SMM with diabetes, hypertension, obesity, or mental health diagnosis, the 
case was included into the data set. I focused the analysis on pregnancy-related 
conditions rather than preexisting conditions, which were defined using the ICD-10-CM 
codes listed in Appendix B.  
 I controlled for four covariates: age, patient location, Medicaid insurance, and 
race/ethnicity. Patient location was defined using the Urban Influence Codes, which 
include large metropolitan areas with at least 1 million residents, small metropolitan areas 
with less than 1 million residents, micropolitan areas that are distinguished by nonmetro 
size and adjacency to other metro areas, and neither metropolitan nor micropolitan. 
Payment was grouped into Medicaid and other, which included self-pay, Medicare, and 
private; this was pertinent because about half of births are covered by Medicaid in 
Michigan (MDHHS, 2018). Race was categorized into three categories: non-Hispanic 
White, non-Hispanic Black, and Other, which included Hispanic, Asian or Pacific 
Islander, Native American or Other. Cases without race were excluded.  
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 I used logistic regression models and cross tabulations to obtain estimates of 
pregnancy-related health conditions to estimate the rates at which any one delivery 
hospitalization had any of the health conditions. Data were pooled into a 2-year period to 
increase precision in the analysis. Prevalent conditions were compared with age, race, 
patient location, and payer with an adjusted odds ratio associated with SMM. Two 
models were used for all subgroups to generate the differences between women 
experiencing SMM and women experiencing SMM and a health condition. Two-tailed p 
values (p < .001) were considered statically significant using SPSS. The SMM data were 
uploaded into the ArcGIS system to map the percentage of the four health conditions and 
SMM by zip code as well as race and ethnicity and SMM.  
Results 
The total number of women delivering in a hospital setting from 2016–2017 was 
202,514 unique cases. The cohort consisted of delivery hospitalizations among non-
Hispanic White (n = 138,937); non-Hispanic Black (n = 39,485); and Hispanic, Asian or 
Pacific Islander, Native American or Other (n = 24,092). Medicaid paid for 
approximately 41.5% of all deliveries; among non-Hispanic Black deliveries, Medicaid 
covered 67.6% (CI 67.1–68.0); among non-Hispanic White 32.8% (CI 32.6–33.1) of 
deliveries; and Hispanic, Asian or Pacific Islander, Native American, or Other 48.9% (CI 
(48.3–49.6) of deliveries. Women were predominately 19–34 years old between all races, 
with the non-Hispanic Black age at 26.49 (CI 26.43–26.55); non-Hispanic White age at 
28.86 (CI 28.83–28.89); and Hispanic, Asian or Pacific Islander, Native American, or 
Other age at 28.85 (CI 28.78–28.92). Non-Hispanic Black women had the highest rate of 
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teen pregnancy (5.0%), and Hispanic, Asian or Pacific Islander, Native American, or 
Other had the highest rate of deliveries over the age of 35 years old (17.6%). 
Table 2 
 
Sociodemographic Characteristics of Delivery Women by Race and Ethnicity, Michigan, 
2016-2017 
Characteristics Non-Hispanic White 
N 
% (95% CI) 
Non-Hispanic Black 
N 
% (95% CI) 
Hispanic, Asian or Pacific Islander, 
Native American or Other 
N 




39,485                   
26.49 (26.43-26.55) 
24,092                                        
28.85 (28.78-28.92) 
Insurance    
     Medicaid 45,627 
32.8 (32.6-33.1) 
 
26,671                     
67.6 (67.1-68.0) 
11,790                                              
48.9 (48.3-49.6) 
     Other 93,300 
67.2 (66.9-67.4) 
12,810                     
32.4 (31.2-32.9) 
12,301                                            
51.1 (50.4-51.7) 
Geographic location    




12,229                                          
50.8 (50.2-51.4) 
    




9,909                                                
41.2 (40.6-41.8) 
    
     Micropolitan 58,026 
12.8 (12.6-12.95) 
270                      
0.68 (0.61-0.77) 
1,465                                             
6.09 (5.8-6.4) 
    




467                                                    
1.94 (1.8-2.1) 
Note. N = 202,514.Table 3 includes all delivery hospitalizations  
The largest number of patient’s reside in a large metro geographic location 
(45.5%). The racial and ethnic distribution for large metro area was non-Hispanic White 
(57.6%); non-Hispanic Black (29.1%); and Hispanic, Asian or Pacific Islander, Native 
American, or Other (13.3%). However, Table 2 indicates the proportion of non-Hispanic 
Black women living in large metro areas, such as inner cities, was highest 68% (CI 67.5–
54 
 
68.5), whereas the highest proportion of non-Hispanic White women live in small 
metropolitan areas (41.8%; CI 41.5–42.1), such as suburbs.  
Among all delivery hospitalizations, mental health diagnosis was the most 
frequent diagnosis (17.7%), followed by obesity (15.8%), diabetes (8.1%), and 
hypertension (3.3%). Compared with deliveries among non-Hispanic White women, 
deliveries among non-Hispanic Black and Hispanic, Asian or Pacific Islander, Native 
American, or Other had higher prevalence of nearly every health condition examined, 
including diabetes, obesity, and hypertension with the exception of a mental health 
diagnosis. Proportionally, racial and ethnic women experienced these health conditions 
more frequently than their non-Hispanic, White counterparts when comparing within race 
(see Table 3).  
The highest proportion of women living with diabetes was Hispanic, Asian or 
Pacific Islander, Native American, or Other at 12.6% (CI 12.2–13.0). The highest 
proportion of women living with obesity was non-Hispanic Black women at 17.9% (CI 
17.5–18.3) compared with non-Hispanic White women at 15.3% (CI 15.1–15.4) and 
Hispanic, Asian or Pacific Islander, Native American, or Other women at 15.8% (CI 
15.4–16.3). Mental health diagnosis was most common in non-Hispanic White women 
with 19.7% (CI 19.5-19.9). The highest percentage of diabetes was found in the Hispanic, 















% (95% CI) 
Non-Hispanic Black 
N 
% (95% CI) 
Hispanic, Asian or Pacific Islander, 
Native American or Other 
N 
% (95% CI) 
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Mental heealth    
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Note. N = 202,514. All univariate analysis between race and the four health conditions were significant (p < .05) 
 
Severe Maternal Morbidity 
In total I identified 2,460 delivery hospitalizations with a SMM indicator, 
representing 1.2% of all delivery hospitalizations in Michigan, which is a rate of 121.5 
per 10,000 deliveries. The highest number of women with SMM were non-Hispanic 
White (n = 1,334), followed by non-Hispanic Black (n = 800) and Hispanic, Asian or 
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Pacific Islander, Native American or Other (n = 326), which trended with the overall 
proportion of each race/ethnicity. However, the rates varied across race and ethnicity; the 
SMM rate for non-Hispanic White was (1%) 100 per 10,000 deliveries, non-Hispanic 
Black was (2%) 200 per 10,000 deliveries and Other was (1.4%) 140 per 10,000 
deliveries, all were significant p < .05. The sociodemographic model in Table 5 depicts 
the SMM and age, location, and race. The patient’s location was the greatest predictor of 
SMM (p < .001), followed by race and ethnicity (p < .001). 
Medicaid insurance covered about half of the deliveries for women who 
experienced an SMM event (49.9%). Although insurance type was statically significant, 
women who had Medicaid insurance (OR 1.20, 95% CI:1.1–1.3) had similar odds of 
having an SMM event with women who had Medicaid without a health condition (OR 
1.23, 95% 1.1-1.3). Non-Hispanic Black women who experienced a SMM had a higher 
rate of Medicaid insurance coverage (67.6%), compared to non-Hispanic White women 
(32.8%) and Hispanic, Asian or Pacific Islander, Native American, or Other (49%). 
Severe Maternal Morbidity, Health Conditions and Race/Ethnicity 
For the women who had a SMM event, the percentages of the four health 
conditions associated with pregnancy complications were diabetes (10%), obesity (20%), 
mental health diagnosis (19.6%), and hypertension (6.3%). In total, across all racial and 
ethnic groups, 56% of women with an SMM outcome experienced one or more health 
conditions. Table 5 depicts the sociodemographic model with health outcomes where 
diabetes was the only health condition not statistically significant with SMM as an 
outcome (p = 0.086). Women with hypertension had the highest risk associated with 
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SMM (OR 1.56, 95% CI:1.3–1.8), followed by obesity (OR 1.23, 95% CI:1.1–1.4), and 
mental health diagnosis (OR 1.19, 95% CI:1.1–1.3). Women with hypertension had the 
highest chance of SMM (OR 1.56, 95% CI:1.3–1.8), with non-Hispanic Black women 
experiencing hypertension more frequently than non-Hispanic White and Hispanic, Asian 
or Pacific Islander, Native American, or Other. Women with at least one health condition 
were anywhere from 1.20—1.50 (95% CI:1.1–1.8) times likely to experience SMM 
compared to women without these conditions.  
Table 4 
 
Adjusted Odds Ratio (OR) associated with severe maternal morbidity in Michigan, 2016-
2017 
   Sociodemographic Model  Sociodemographic Model with Health 
Conditions 
Age at Delivery ChiSquare OR LB UB ChiSquare OR LB UB 
19-34 years vs under 18 
years 
 
0.07 0.82 0.66 1.01 0.03 0.78 0.63 0.97 
Over 35 years vs under 18 
years 
 
0.32 1.13 0.89 1.43 0.87 1.02 0.80 1.29 
Over 35 years vs 19-34 
years 




Large metro vs small metro 
 
<.0001* 1.81 1.65 1.99 <.0001* 1.84 1.67 2.02 
Large metro vs 
micropolitan 
 
<.0001* 1.42 1.21 1.67 <.0001* 1.43 1.22 1.68 
Small metro vs 
micropolitan  




Medicaid vs other (private, 
medicare, self-pay) 




Non-Hispanic Black vs 
non-Hispanic White 




Hispanic, Asian or Pacific 
Islander, Native American 
or Other vs non-Hispanic 
White 
 
<.0001* 1.31 1.15 1.48 <.0001* 1.34 1.78 1.51 
Hispanic, Asian or Pacific 
Islander, Native American 
or Other vs non-Hispanic 
Black 
<.0001* 0.73 0.64 0.84 <.0001* 0.75 0.67 0.87 
 
Chronic conditions Associated with Pregnancy 
 
Diabetes (Yes vs No) 
 
    0.09 1.13 0.98 1.29 
Obesity (Yes vs No) 
 
    <.0001* 1.23 1.11 1.36 
Mental Health/ Substance 
use (Yes vs No) 
 
    <.0008* 1.19 1.08 1.32 
Hypertension (Yes vs No)     <.0001* 1.55 1.31 1.85 
Note. N = 202,514. Stastical significance was demonstrated by * (p < .05) 
 
Severe Maternal Morbidity, Health Conditions, and Geographic Location 
Spatial distribution of risk factors for maternal ill-health (SMM) were modeled by 
adverse maternal health conditions indicated as independent variables. The use of 
geographic methods for modeling the effect of risk factors on SMM was minimal; 
logistic regression portrayed geographic location as the greatest predictor of SMM and 
GIS was utilized as a means to describe the analysis. The statistical modeling assumes 
that the statistical associations were affected by geography. These results portray the 
number, percent, and density of SMM with health conditions across Michigan. Counts 
and percentages were categorized by natural breaks and quartiles, respectively. Results 
provided three sets of maps; each analysis was depicted by the zip code where the patient 
lived or where the patient indicated during their hospital stay.  
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The SMM 2016-2017 map depicts the number of SMM during the time period 
2016-2017. The highest number of SMM cases occurred in three different zip codes in 
Southeast Michigan, which had 33-45 SMM cases between 2016-2017. The zip codes 
with the highest SMM were Pontiac (33), Taylor (39), Dearborn (37), and the highest in 
Detroit (45). The areas with the lowest SMM rates were in rural parts of Michigan, likely 
due to population density. The highest number of disease diagnosis for the four health 
conditions were as follows; SMM and diabetes was Dearborn, Inkster, Belleville; SMM 
and hypertension was Detroit and Saginaw; SMM and obesity was Detroit; SMM and 
mental health diagnosis was Lapeer, Saginaw, Lansing, Pontiac, Warren, Taylor, Wayne, 
Ypsilanti, and Jackson. The second set of maps was a collection of three maps depicting 
SMM by the percent of race/ethnicity groups per zip code. The third set portrays the 







































Figure 2. Percent of severe maternal morbidity for hispanic, asian or pacific islander, 




































The full logistic regression model indicated that geographic location was the 
greatest predictor of SMM and health conditions associated with pregnancy complication. 
The second greatest predictor was race, followed by hypertension diagnosis, age, 
insurance (payer), obesity, and mental health diagnosis. For the first study hypothesis, I 
rejected the null hypothesis that there are no differences in severe maternal morbidity 
rates among geographic location and racial/ethnic (non-Hispanic Black, Hispanic, Asian 
or Pacific Islander, and Native American, or Alaska Native) women. I rejected the null 
hypothesis that there are no geographic variations of severe maternal morbidity across the 
state of Michigan. I rejected the null hypothesis that there are no racial and ethnic 
variations of severe maternal morbidity across the state of Michigan. I rejected the null 
hypothesis that there are no racial/ethnic variation between women who have experience 
hypertension, obesity or mental health diagnosis. Finally, I failed  to reject the null 
hypothesis that there are no racial/ethnic variation between women who have a diabetes 
diagnosis and SMM outcome.  
We found that the average SMM rate for Michigan residents was (1.2%) 121.5 
per 10,000 deliveries. However, the rates varied across race and ethnicity with the non-
Hispanic Black population having the highest rate of SMM (200 per 10,000 deliveries). 
In order to better understand these associations, specifically geographic location 
variation, I used data visualization techniques. I used spatial analysis to determine the 
location of areas where women had a health condition and experienced SMM during their 
delivery hospitalization. The set of maps that depicts the percent of health conditions with 
69 
 
an SMM outcome to accurately inform which disease interventions would help women in 
a specific zip code.  
 The third set of maps demonstrated the four health conditions by zip code that 
were most prevalent during the SMM events. For example, the highest number of obesity 
diagnosis and SMM were located in Detroit. However, the highest percentage of obesity 
occurred in more rural and small metro locations such as Sault Saint Marine, Pickford, 
Kinross, Hawks, Atlanta, Alger, Gladwin, Hastings, Holland, Decatur, Coloma, Minden 
City, Elkton, and more; that is where 100% of the cases were obese on admission. 
Similarly, the highest number of diabetes diagnosis was in Dearborn, Inkster, Belleville, 
but the highest percentage of diabetes was located in small metros or rural locations like 
Dewitt, Alanson, Bad Axe, Casco, Dundee, and more.  
These findings present a review of delivery hospitalizations in Michigan from 
2016-2017, severe maternal morbidity as an outcome, and four health conditions 
associated with pregnancy complications that may exacerbate the chances of an SMM 
event. Secondly, the racial and ethnic variation in disease outcome, as well as the 
variation in health conditions across the State, was identified. The geographical variation 
in both health conditions and racial and ethnic diversity was depicted via GIS 
technologies. Evaluating geographic patterns in the association between four health 
conditions and SMM introduced more detailed descriptions of where women are 
experiencing poor health outcomes. Although geographical representation remains on the 
periphery of many maternal health analysis, these results demonstrate need for 
visualization techniques for the association between geographic location and SMM to 
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pinpoint areas of greatest need that inform public health professionals to make social 
changes, which is outlined in the following section.  
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Section 4: Application to Professional Practice and Implications for Social Change 
Introduction 
SMM is an ongoing problem that affects more than 50,000 women annually 
(Callaghan et al., 2012). There is a public health need to improve reproductive health 
services with the intent to improve health equity while increasing the number of healthy 
pregnancies and deliveries. In a response to this public health issue, during the past 
decade, reducing poor maternal health outcomes has been a leading priority with the U.S. 
Department of Health and Human Services, declaring the reduction of pregnancy-related 
complications and illness a Healthy People 2020 objective (HealthyPeople, 2017). 
However, there is still work to be done. The physical and psychological ailments that 
directly and indirectly affect women’s health contribute to a myriad of consequences, 
including ill-health, loss of workdays, inability to bond with baby, sleeplessness, and 
trauma (Mazul et al., 2017). Since SMM occurs 100 times more frequently than maternal 
mortality (Admon et al., 2017), SMM surveillance is impactful for monitoring maternal 
outcomes while providing population-level context and geographical differences for 
public health interventions.  
Defining methods for identifying SMM at the population-level utilizing ICD-10-
CM diagnosis and procedure codes for delivery hospitalizations to describe trends and 
health disparities will help states inform maternal morbidity interventions. While there 
are maternal health impacts, there are challenges navigating the correct diagnosis and 
procedure codes as well as trying to understand the diverse data systems to examine the 
patterns and risk factors to implement upstream interventions (Conrey et al., 2019). There 
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is limited published information that establishes how states are tracking SMM, what data 
they are using, and the subsequent policy and interventions based on the findings. The 
purpose of this study was to describe SMM in Michigan, depict where SMM and health 
conditions related to pregnancy complications occur, and address the infrastructure to 
improve health equity while focusing on efforts to reduce maternal morbidity.  
Interpretation of the Findings 
I used spatial epidemiology to advance the assessment of risk factors for SMM, 
obesity, hypertension, mental health diagnosis, and diabetes. These health conditions, 
described in the literature as risk factors that fall within social determinants of risk, were 
examined as characteristics in a complex pathway leading to poor maternal health 
outcomes. However, the differences in SMM rates are complex, and researchers have 
examined patient characteristics, systems, healthcare professional, and facility because 
they contribute to obstetrical care (Hirshberg & Srinivas, 2017). Access to adequate 
perinatal care aiding in prevention against maternal morbidities and mortalities has been 
found as a protective factor; yet, researchers have identified barriers and challenges to 
preconception, prenatal, and postpartum care due to unplanned pregnancies, competing 
priorities, and limited time in the clinic setting, respectively (Khan, Boyle, Lang, & 
Harrison, 2019; Mazul, Ward, & Ngui, 2017). The findings of this study added to that 
current knowledge while identifying geographic disparities in Michigan as well as 
pinpointing specific gaps for disease-specific interventions. 
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Socioecological Model, Critical Race Theory, and Severe Maternal Morbidity 
Each SMM is unique and poses its own set of risk factors, systemic barriers, and 
health outcomes for each individual. Each woman lives within a complex socioecological 
framework, where each interaction with public policy, their community, the organizations 
they frequent and interact within, as well as their social networks and individual 
experiences impact their daily lives. Generational trauma and exposure to chronic stress 
has shaped the socioecological system women are born into and grow accustom to. 
Different lived experiences contribute to how an individual may access preconception, 
perinatal, and postpartum health services as well as the number of interactions with the 
healthcare system (Cabacungan, Ngui, & McGinley, 2012). This may be due to monetary 
resources, implicit or explicit bias from providers, geographic location, or insurance type 
(Khan, Boyle, Lang, & Harrison, 2019). It is important to note that the individual 
differences in health status, as well as healthcare access, should be taken into 
consideration when analyzing data based on health outcomes on the basis that healthcare 
access, insurance, and availability is not equal across the state; moreover, racial and 
ethnic disparities persist across the Michigan for SMM rates.  
Analyzing health data is only one step towards providing intervention 
recommendations and rationale for resources and funding, so it is critical to include a 
historical context for more accurate findings and subsequent recommendations. Sharing 
these racial and ethnic disparities while framing this analysis around the socioecological 
theory alone was inadequate. It was vital to introduce the critical race theory due to an 
U.S. history of White privilege, where White individuals have been protected by the 
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government, financial institutions, policy forces, and have been prioritized for safety and 
resources. The racial and ethnic health disparities, perpetuated by structural barriers, are 
still heavily documented in the literature; college-educated, Black women are 3 times 
more likely to experience maternal complications than White women without a high 
school education, and women living in geographically underserved areas present with 
more health conditions (New York City Department of Health and Mental Hygiene, 
2016). The structural barriers persist for racial and ethnic women and contribute to higher 
rates of poor health. Bohren et al. (2015) found that mistreatment of women during 
childbirth in a healthcare setting contributes to morbidity and mortality. Therefore, the 
multifaceted interactions of a history of racial inequities and individual and 
environmental networks contribute to health outcomes, and when coupled with 
intergenerational trauma, women’s lives are completely altered.  
The exposure to chronic stress and lack of trust in the healthcare system is now 
understood be to a reason why marginalized ethnic women have greater rates of poor 
health outcomes and other chronic illnesses compared to non-Hispanic White women 
(McKinnon et al., 2016). This has been an ongoing public health issue for more than 40 
years; from 1979 to 2010, Black women had a twofold higher rate of chronic 
hypertension than White women (Ananth et al., 2019). Not only do health conditions 
contribute to ill-health, but unfair treatment by the society at large has led to detrimental 
effects on pregnancy outcomes, often leading to SMM or sequalae of an adverse risk 
during delivery (Williams, Priest, & Anderson, 2016). Greater attention to understanding 
risks and resources in the social environment that are linked to geographic location; 
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race/ethnicity; and how that accumulation of innate, environmental, and acquired factors 
across the life course perpetuates or remedies health outcomes to influence SMM rates is 
necessary in making a social change.  
Health Conditions 
In addition to the racial and ethnic disparities, many women who have chronic, 
mismanaged, or underdiagnosed health conditions experiences higher rates of SMM 
(Creanga, Syverson, Seed & Callaghan, 2017). Providing targeted interventions for 
women experiencing these conditions is especially important, but the interventions are 
often inadequately delivered. The prevalence of diabetes among women during 
reproductive years has increased, disproportionately affecting racial and ethnic women 
further perpetuating poor health outcomes (Bardenheier et al., 2015; Deputy et al., 2018). 
When these health conditions are diagnosed before pregnancy, healthcare providers can 
counsel on interventions that may postpone, delay, treat, or manage any additional harm 
to the mother and infant. However, when these health conditions are not established 
before conception or during the perinatal period, severe maternal and infant 
complications can occur. In fact, only about half of postpartum women with existing 
diabetes report receiving preconception care (Kim, Deputy, & Robbins, 2018). Treating 
women with respect and dignity by managing health conditions associated with 
pregnancy complications is one way to interpret these findings and create social impact.  
Lastly, the mental health diagnosis and increased contribution of behavioral 
health conditions linked to cases of SMM has been identified as an emerging concern. 
The findings of this study reveal higher prevalence of mental health diagnosis for non-
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Hispanic White women. However, underreporting for racial and ethnic women may 
contribute to a disparity in screening and referral to treatment. The possibility of racial 
and ethnic women receiving less adequate care by way of underdiagnosed and 
understudied mental health conditions requires a deeper analysis across healthcare 
services. Universal screening and referral to evidence-based treatment may benefit 
women and remedy a systematic barrier. Similarly, other health conditions may showcase 
system-level disparities for current screening and referral practices.  
In this study, I quantified the magnitude of racial and ethnic disparities as well as 
geographic location and the prevalence of SMM among women who deliver in Michigan. 
My two main interpretations of this data are: (a) racial and ethnic inequities persist and 
(b) there is a relationship between geography and health conditions. Identifying the areas 
where healthcare services are needed is imperative for the fair and just distribution of 
these services. Healthcare systems can provide powerful resources, such as preventative 
initiatives to reduce the burden of disease. Shifting the responsibility to healthcare 
systems, instead of individual responsibility, by equipping health systems with 
surveillance and effective monitoring, such as GIS, will help identify the needs of 
vulnerable communities to address individual needs and systematic problems.  
Limitations of the Study 
Statewide administrative data are validated before final submission into the 
HCUP; however, these diagnosis and procedure codes do not provide information on 
prenatal care, the severity of a condition, or follow-up outside of the hospital setting; the 
cross-sectional nature of the data limits the knowledge of whether the conditions have 
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changed over time, between racial groups, or led to a mortality. Administrative databases 
that lack patient characteristics, such as age and body mass index, may lack necessary 
information (Grobman et al., 2015). 
The data lack some socioeconomic fields, smoking status, primary language, and 
other demographics that may contribute to inadequate health care services and potentially 
SMM (Metcalfe et al., 2018). It is also possible that an increased SMM rate may reflect 
rigorous coding practices over time (Admon et al., 2017). Moreover, I only accounted for 
the CDC’s definition of SMM, which includes 18 indicators that correspond with ICD-10 
codes identified only during the hospitalization of record, in this study.  
I examined four of the health conditions associated with pregnancy complications 
and did not do a full analysis of all health-related complications. There are other leading 
diagnosis-based indicators of SMM that include adult respiratory distress syndrome and 
acute renal failure (CDC, 2018; New York City Department of Health and Mental 
Hygiene, 2016). Finally, this study lacks information regarding preconception obstetric 
care received that has benefits to reduce maternal morbidity and poor health outcomes. 
The findings should be interpreted considering the limitations of the data source, study 
design, and geographic visualization methodology. Expanding inclusive maternity care 
management programs that integrate preconception health through the first year 
postpartum, particularly among racial and ethnic women with a prior health conditions, 




In this study, geographic location was the greatest predictor of SMM with race 
and ethnicity being a close second. This geographic and racial SMM analysis presented 
opportunities to examine these disparities more closely. Poor health conditions contribute 
to the health disparities across Michigan, and the number of racial and ethnic women 
living with a health condition is higher when compared with their White counterparts. I 
recommend a deeper analysis into the four health conditions related to pregnancy 
outcomes examined in this study (i.e., mental health diagnosis, diabetes, obesity, and 
hypertension) and the relationship with sociodemographic factors, such as poverty, 
neighborhood resources, and social support. While there is evidence of increased focus 
on describing patterns of maternal morbidity, the collective impact of morbidity and the 
extent to which it effects women is poorly understood. The varying effects SMM has on 
women can be exacerbated by the environment and conditions in which they live; living 
with poverty, racial inequalities, multiple health conditions, and inadequate resources 
during pregnancy compound and can result in poor mental health and a litany of other 
physical diagnoses. The physical and psychological function of a woman experiencing a 
SMM event may dissipate after childbirth; however, the sequelae of poor birth 
experiences in addition to health conditions, fatigue, pain, depression, anxiety, and restful 
sleep may continue to impact a woman’s day-to-day functioning and disproportionately 
effect racial and ethnic women.  
The nuances prompt another layer of exploration. In addition to other analysis, 
collecting qualitative data to examine the lived experiences and world views of women 
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and families impacted by SMM could provide more information into the overall trends 
and why certain zip codes experience disparities. The daily structural and social barriers 
women face can be detrimental to their health and can contribute to poor pregnancy 
outcomes. Conducting a mixed methods approach to SMM could help elucidate the social 
determinants of disease and potentially identify modifiable risk factors that contribute to 
one area more than another.  
Each health condition is uniquely complex in relationship to pregnancy, thus a 
deeper analysis into the interplay between health conditions, sociodemographic risk 
factors, and SMM may provide richer results. Each of the four health conditions present 
vastly different upstream interventions effecting women differently depending on where 
they live and the resources easily available to them, especially mental health, 
hypertension, and diabetes diagnosis. These health conditions have more granular 
information that may provide more definitive results. This is due, in part, to the mental 
health diagnosis including alcohol, tobacco and substance use during pregnancy, while 
hypertension and diabetes include preexisting and gestational diagnosis. Moreover, these 
health conditions, coupled with a history of unfair treatment, effect racial and ethnic 
groups disproportionately and, as a result, have led to disparate health outcomes. Thus, it 
is our recommendation that each health condition associated with pregnancy 
complications be studied in its relationship to severe maternal morbidity and what that 
means for women living in geographically diverse areas. Finally, an exploration on cost 
savings pertaining to the different health conditions and SMM interventions may provide 
useful. Comparing intervention costs, health care costs, childcare costs, and the societal 
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costs including lost workdays, long-term rehabilitation, and mental health services may 
provide reason to explore more upstream interventions. Estimating cost savings could 
help resources and policy interventions to create sustainable social change for all effected 
by SMM.  
Implication for Professional Practice and Social Change 
The higher rates of SMM for non-Hispanic Black, Hispanic, Asian or Pacific 
Islander, Native American, and/or Other races and ethnicities have been the subject of 
considerable attention. The persistent gaps in risk between non-Hispanic White women 
and other races and ethnicities has plagued the public health realm. Yet, the inequities 
continue. In the February 2020 issue of Obstetrics and Gynecology, Dr. William M 
Callaghan states,  
“Health and medical care exist in the context of the larger society, and our failure 
to address the needs of women and the inequities borne by marginalized 
populations is a reflection of reconciling what we say we value and what we do to 
achieve our valued goals (Callaghan, 2020).”  
Addressing the SMM problem with changes to the professional field, first by focusing on 
health equity and systems change, is the only acceptable way to tackle this public health 
problem. The changes in practice will require social change within organizations, clinical 
practices, local health departments, schools, governmental bodies and anywhere women 
seek services, treatment, and support.  
 There are three main implications resulting from the findings. The first is that 
among all four health conditions explored, three of those conditions emerged as 
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important risk factors associated with SMM. Second, the results support an emphasis on 
preconception health and access to pregnancy services that aligns with statewide and 
national strategies. Finally, these implications shared with stakeholders in Michigan may 
help prioritize strategies to prevent the increased maternal morbidity rates.  
Professional Practice  
This analysis prompts a call to action for those striving to improve access to 
healthcare services prior to delivery for women living in Michigan. It is evident that 
adverse pregnancy and health outcomes persist among racial and ethnic health women 
who live in large metropolitan zip codes. These findings suggest interventions based on 
the patient’s location may prove an innovative way to tailor resources for specific 
healthcare needs. For example, focusing efforts on reducing SMM geographically has 
been shown to be effective for women living in in resource-poor areas (Suplee, Bloch, 
Hillier, & Herbert, 2018).  
For professionals working with women and children, providing GIS maps of 
SMM with information regarding the health conditions that complicate pregnancy may 
help providers engage with community organizations to modify interventions for the 
greatest needs. Enhanced surveillance of SMM can help identify preventability and 
outline actionable recommendations to mitigate poor maternal health outcomes and 
optimize maternal health service delivery. Sharing population-level data with public 
health and clinical health providers will improve their understanding of factors that 
contribute to health disparities. Understanding the zip codes where women return, after a 
delivery hospitalization, and the related patterns of health in those areas, as well as 
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recurring health outcomes can impact perinatal health care interventions to tailor specific 
needs.  
GIS maps assist in targeted implementation interventions that impact women to 
positively impact her health throughout her life course. This includes contraception 
access and family planning services, preconception health that helps manage health 
conditions, and providing accessible perinatal care and education across the state 
(Robbins et al., 2018). Importantly, enrolling women in insurance programs before they 
become pregnant and ensuring that women and infants have insurance until one year after 
birth may impact SMM rates (Ranji, Gomez, & Salganicoff, 2019). Finally, providing 
wrap around services by creating relationship with women prior to pregnancy, assisting 
her while pregnant, and supporting her in the recovery after childbirth and during the 
postpartum period is an opportunity to reduce health disparities and feelings of fear of the 
healthcare system. Providing long-term care for women prior to pregnancy, throughout 
pregnancy and postpartum would remedy the social barriers of geographic isolation, 
problematic health conditions, and offer hope for lasting social change in the maternal 
healthcare delivery system.  
Social Impact  
Geospatial analysis has grown in popularity to advance precision public health 
initiatives. Precision public health focuses on the use of technologies (such as GIS) to 
deliver the correct intervention at the right time to the right population (Khoury, 
Iademarco, & Riley, 2016). This would guide public health practice to individually 
tailored interventions and policies that may benefit the public with more precise 
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interventions and medicine. Moreover, this approach leads to social change and disease 
treatment because it takes into consideration the individual variability, environment and 
lifestyle.  
The data demonstrates that specific zip codes and neighborhoods have higher 
rates of SMM than others and clinical, public health, and policy interventions can be 
directed to those areas. The findings of this study support the need for enhanced 
screening and timely treatment for racial and ethnic women. While the graphs in the 
results do not demonstrate the exact location of disease, they pinpoint areas with greater 
risk. Taking into consideration precision public health, these maps may be a helpful tool 
in beginning the alignment of resources for the greatest need. Moreover, GIS allows local 
government to consider policy changes to be considered for lasting social change. By 
utilizing precision public health, localities can provide context for additional efforts 
among populations with limited resources, greater risk of a health condition, and have the 
greatest social impact. Professional practice can have a great deal of impact on social 
well-being. When a woman seeks care from a professional, they trust the professional 
will pose the least amount of harm on them. Identifying opportunities to change deeply 
rooted professional practices will ultimately create a compound of social change 
benefiting women and their families. When professionals advocate for women and their 
health, families, and societies benefit for a more harmonious lived experience.  
Conclusion 
Increases in maternal mortality rates over recent years has prompted more 
national attention on women’s health. Maternal morbidity is a continuum of short-term 
84 
 
adverse effects to long-term life-altering events and are 100 times more common than 
maternal mortality. However, defining maternal morbidity as the unintended outcomes of 
pregnancy that results in a significant short or long-term consequence to a women’s 
health may overlook some of the environmental, societal, or delayed onsets of SMM. The 
prevalence of death remains low overall, however maternal death only showcase the 
more obvious aspects of healthcare delievery with respect to the number of pregnancies 
and pregnancy complications. Complications due to health conditions and maternal 
mental health have not been examined as closely, leading many to explore risk factors, 
health disparities, and access to quality healthcare in SMM. This research is an important 
step in understanding the precursors to morbidity and the remaining, less obvious, 90% of 
healthcare delivery.  
SMM was identified at significantly higher frequency across racial and ethnic 
women, which are consistent with findings identified in Admon et al. (2017) nationwide 
analysis. The data suggests that racial and ethnic women have a significant proportion of 
obstetric complications, many of which are preventable, and improved quality of 
healthcare interventions are a considerable key factor in the prevention of maternal 
morbidity. The implementation of precision public health interventions for health 
condition management, as well as hospital centric interventions including the Alliance for 
Innovation safety bundles and racial and ethnic disparities bundles are actionable steps 
that can be taken to reduce disparities in poor obstetric outcomes. Disparities will not be 
eliminated by improved public health interventions or hospital safety bundles alone. 
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Implicit bias trainings, cultural sensitivity and health literacy trainings are also needed to 
create social change in healthcare environments.  
In summary, we found racial and ethnic disparities in overall severe maternal 
morbidity among non-Hispanic Black, Hispanic, Asian or Pacific Islander, and Native 
American compared with non-Hispanic White women. The prevalence of health 
conditions associated with SMM varied geographically and provided insight into 
identifying opportunities for public health interventions. It is clear that within zip codes 
and between zip codes there are health inequalities in morbidity rates. Whether those 
differences in morbidity rates are related to access to quality healthcare, hospital services, 
or perinatal care is unclear. However, within the broader health context, there continues 
to be a debate around the relationship between health and place, as well as the bases of 
health inequities (Ballas et al., 2017). Health is qualified at an individual level, but 
healthcare issues are geographical in nature. Individual health is determined by a 
multitude of predisposing factors, but also personal geographic. Where an individual was 
raised, where they live, work, play, and all of which affect health outcomes, ill-health and 
access to healthcare, as well as the quality of treatment available.  
In closing, exposure to environmental factors are spatially clustered but behaviors 
are also inherently linked to geographic locations such as zip codes. Health behaviors, 
access to quality care, social environmental, and stressors tend to spatially cluster 
effecting individuals similarly in specific areas. There is a clear correlation between 
geographic ill-health and health needs. Tools to identify health conditions by underlying 
demographic and indicators have been identified. I have identified GIS as an important 
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tool for visualizing health disparities and evaluating areas where improved interventions 
are necessary. Thus, I must strive for deeper analysis, and consistent levels of care 
relative to geographic need in order to protect and promote women’s health for 
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Appendix A: Center for Disease Control and Preventions Severe Maternal Morbidity 
Indicators 




ICD-10  Descriptions 
  1. Acute myocardial infarction  
  
  I21.01 ST elevation (STEMI) myocardial infarction 
involving left main coronary artery 
  I21.02 ST elevation (STEMI) myocardial infarction 
involving left anterior descending coronary artery 
  I21.09 ST elevation (STEMI) myocardial infarction 
involving other coronary artery of anterior wall 
  I21.11 ST elevation (STEMI) myocardial infarction 
involving right coronary artery 
  I21.19 ST elevation (STEMI) myocardial infarction 
involving other coronary artery of inferior wall 
  I21.21 ST elevation (STEMI) myocardial infarction 
involving left circumflex coronary artery 
  I21.29 ST elevation (STEMI) myocardial infarction 
involving other sites 
  I21.3 ST elevation (STEMI) myocardial infarction of 
unspecified site 
  I21.4 Non-ST elevation (NSTEMI) myocardial 
infarction 
  I21.9 Acute myocardial infarction, unspecified 
  I21.A1 Myocardial infarction type 2 
  I21.A9 Other myocardial infarction type 
  I22.0 Subsequent ST elevation (STEMI) myocardial 
infarction of anterior wall 
  I22.1 Subsequent ST elevation (STEMI) myocardial 
infarction of inferior wall 
  I22.2 Subsequent non-ST elevation (NSTEMI) 
myocardial infarction 
  I22.8 Subsequent ST elevation (STEMI) myocardial 
infarction of other sites 
  I22.9 Subsequent ST elevation (STEMI) myocardial 
infarction of unspecified site 




  N17.0 Acute kidney failure with tubular necrosis 
  N17.1 Acute kidney failure with acute cortical necrosis 
  N17.2 Acute kidney failure with medullary necrosis 
  N17.8 Other acute kidney failure 
  N17.9 Acute kidney failure, unspecified 
  O90.4 Postpartum acute kidney failure 
  3. Adult Respiratory Distress Syndrome diagnosis 
  
  J80 Acute respiratory distress syndrome 
  J95.1 Acute pulmonary insufficiency following thoracic 
surgery 
  J95.2 Acute pulmonary insufficiency following 
nonthoracic surgery 
  J95.3 Chronic pulmonary insufficiency following 
surgery 
  J95.821 Acute postprocedural respiratory failure 
  J95.822  Acute and chronic postprocedural respiratory 
failure 
  J96.00 Acute respiratory failure unspecified whether with 
hypoxia or hypercapnia 
  J96.01 Acute respiratory failure with hypoxia 
  J96.02 Acute respiratory failure with hypercapnia 
  J96.20 Acute and chronic respiratory failure unspecified 
whether with hypoxia or hypercapnia 
  J96.21 Acute and chronic respiratory failure with hypoxia 
  J96.22 Acute and chronic respiratory failure with 
hypercapnia 
  R09.2 Respiratory arrest 
  4. Amniotic fluid embolism  
  
  O88.111  Amniotic fluid embolism in first trimester 
  O88.112 Amniotic fluid embolism in second rimester 
  O88.113 Amniotic fluid embolism in third trimester 
  O88.119 Amniotic fluid embolism in pregnancy 
  O88.12   Amniotic fluid embolism in childbirth 
  O88.13   Amniotic fluid embolism in puerperium 
   5. Aneurysm  
  
  I71.00 Dissection of unspecified site of aorta 
  I71.01 Dissection of thoracic aorta 
  I71.02 Dissection of abdominal aorta 
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  I71.03 Dissection of thoracoabdominal aorta 
  I71.1 Thoracic aortic aneurysm, ruptured 
  I71.2 Thoracic aortic aneurysm, without rupture 
  I71.3 Abdominal aortic aneurysm, ruptured 
  I71.4 Abdominal aortic aneurysm, without rupture 
  I71.5 Thoracoabdominal aortic aneurysm, ruptured 
  I71.6 Thoracoabdominal aortic aneurysm, without 
rupture 
  I71.8 Aortic aneurysm of unspecified site, ruptured 
  I71.9  Aortic aneurysm of unspecified site, without 
rupture 
  I79.0 Aneurysm of aorta in diseases classified elsewhere 
  6. Cardiac arrest/ventricular fibrillation  
  
  I49.01 Ventricular fibrillation 
  I49.02 Ventricular flutter 
  I46.2 Cardiac arrest due to underlying cardiac condition 
  I46.8 Cardiac arrest due to other underlying condition 
  I46.9 Cardiac arrest, cause unspecified 
  7. Disseminated Intravascular Coagulation 
  
  D65 Disseminated intravascular coagulation 
[defibrination syndrome] 
  D68.8 Other specified coagulation defects 
  D68.9 Coagulation defect, unspecified 
  O72.3 Postpartum coagulation defects 
  8. Eclampsia   
  O15.00 Eclampsia complicating pregnancy, unspecified 
trimester 
  O15.02 Eclampsia in pregnancy, second trimester 
  O15.03 Eclampsia in pregnancy, third trimester 
  O15.1 Eclampsia in labor 
  O15.2 Eclampsia in the puerperium 
  O15.9 Eclampsia, unspecified as to time period 
  9. Heart failure/arrest during procedure or surgery 
  
  I97.120 Postprocedural cardiac arrest following cardiac 
surgery 
  I97.121 Postprocedural cardiac arrest following other 
surgery 




  I97.131 Postprocedural heart failure following other 
surgery 
  10. Internal injuries of thorax, abdomen, and pelvis 
  
  Not carried forward (either very low frequency or imprecise usage) 
  11. Intracranial injuries 
  
  Not carried forward (either very low frequency or imprecise usage) 
  12. Puerperal Cerebrovascular Disorder  
  
  I60.00 Nontraumatic subarachnoid hemorrhage from 
unspecified carotid siphon and bifurcation 
  I60.01 Nontraumatic subarachnoid hemorrhage from 
right carotid siphon and bifurcation 
  I60.02 Nontraumatic subarachnoid hemorrhage from left 
carotid siphon and bifurcation 
  I60.10 Nontraumatic subarachnoid hemorrhage from 
unspecified middle cerebral artery 
  I60.11 Nontraumatic subarachnoid hemorrhage from 
right middle cerebral artery 
  I60.12 Nontraumatic subarachnoid hemorrhage from left 
middle cerebral artery 
  I60.2 Nontraumatic subarachnoid hemorrhage from 
anterior communicating artery 
  I60.20 Nontraumatic subarachnoid hemorrhage from 
unspecified anterior communicating artery 
  I60.21 Nontraumatic subarachnoid hemorrhage from 
right anterior communicating artery 
  I60.22 Nontraumatic subarachnoid hemorrhage from left 
anterior communicating artery 
  I60.30 Nontraumatic subarachnoid hemorrhage from 
unspecified posterior communicating artery 
  I60.31 Nontraumatic subarachnoid hemorrhage from 
right posterior communicating artery 
  I60.32 Nontraumatic subarachnoid hemorrhage from left 
posterior communicating artery 
  I60.4 Nontraumatic subarachnoid hemorrhage from 
basilar artery 
  I60.50 Nontraumatic subarachnoid hemorrhage from 
unspecified vertebral artery 
  I60.51 Nontraumatic subarachnoid hemorrhage from 
right vertebral artery 
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  I60.52 Nontraumatic subarachnoid hemorrhage from left 
vertebral artery 
  I60.6 Nontraumatic subarachnoid hemorrhage from 
other intracranial arteries 
  I60.7 Nontraumatic subarachnoid hemorrhage from 
unspecified intracranial artery 
  I60.8 Other nontraumatic subarachnoid hemorrhage 
  I60.9 Nontraumatic subarachnoid hemorrhage, 
unspecified 
  I61.0 Nontraumatic intracerebral hemorrhage in 
hemisphere, subcortical 
  I61.1 Nontraumatic intracerebral hemorrhage in 
hemisphere, cortical 
  I61.2 Nontraumatic intracerebral hemorrhage in 
hemisphere, unspecified 
  I61.3 Nontraumatic intracerebral hemorrhage in brain 
stem 
  I61.4 Nontraumatic intracerebral hemorrhage in 
cerebellum 
  I61.5 Nontraumatic intracerebral hemorrhage, 
intraventricular 
  I61.6 Nontraumatic intracerebral hemorrhage, multiple 
localized 
  I61.8 Other nontraumatic intracerebral hemorrhage 
  I61.9 Nontraumatic intracerebral hemorrhage, 
unspecified 
  I62.00 Nontraumatic subdural hemorrhage, unspecified 
  I62.01 Nontraumatic acute subdural hemorrhage 
  I62.02 Nontraumatic subacute subdural hemorrhage 
  I62.03 Nontraumatic chronic subdural hemorrhage 
  I62.1 Nontraumatic extradural hemorrhage 
  I62.9 Nontraumatic intracranial hemorrhage, 
unspecified 
  I63.00 Cerebral infarction due to thrombosis of 
unspecified precerebral artery 
  I63.011 Cerebral infarction due to thrombosis of right 
vertebral artery 
  I63.012 Cerebral infarction due to thrombosis of left 
vertebral artery 
  I63.013 Cerebral infarction due to thrombosis of bilateral 
vertebral arteries 
  I63.019 Cerebral infarction due to thrombosis of 
unspecified vertebral artery 
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  I63.02 Cerebral infarction due to thrombosis of basilar 
artery 
  I63.031 Cerebral infarction due to thrombosis of right 
carotid artery 
  I63.032 Cerebral infarction due to thrombosis of left 
carotid artery 
  I63.033 Cerebral infarction due to thrombosis of bilateral 
carotid arteries 
  I63.039 Cerebral infarction due to thrombosis of 
unspecified carotid artery 
  I63.09 Cerebral infarction due to thrombosis of other 
precerebral artery 
  I63.10 Cerebral infarction due to embolism of 
unspecified precerebral artery 
  I63.111 Cerebral infarction due to embolism of right 
vertebral artery 
  I63.112 Cerebral infarction due to embolism of left 
vertebral artery 
  I63.113 Cerebral infarction due to embolism of bilateral 
vertebral arteries 
  I63.119 Cerebral infarction due to embolism of 
unspecified vertebral artery 
  I63.12 Cerebral infarction due to embolism of basilar 
artery 
  I63.131 Cerebral infarction due to embolism of right 
carotid artery 
  I63.132 Cerebral infarction due to embolism of left carotid 
artery 
  I63.133 Cerebral infarction due to embolism of bilateral 
carotid arteries 
  I63.139 Cerebral infarction due to embolism of 
unspecified carotid artery 
  I63.19 Cerebral infarction due to embolism of other 
precerebral artery 
  I63.20 Cerebral infarction due to unspecified occlusion or 
stenosis of unspecified precerebral arteries 
  I63.211 Cerebral infarction due to unspecified occlusion or 
stenosis of right vertebral arteries 
  I63.212 Cerebral infarction due to unspecified occlusion or 
stenosis of left vertebral arteries 
  I63.213 Cerebral infarction due to unspecified occlusion or 
stenosis of bilateral vertebral arteries 
  I63.219 Cerebral infarction due to unspecified occlusion or 
stenosis of unspecified vertebral arteries 
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  I63.22 Cerebral infarction due to unspecified occlusion or 
stenosis of basilar arteries 
  I63.231 Cerebral infarction due to unspecified occlusion or 
stenosis of right carotid arteries 
  I63.232 Cerebral infarction due to unspecified occlusion or 
stenosis of left carotid arteries 
  I63.233 Cerebral infarction due to unspecified occlusion or 
stenosis of bilateral carotid arteries 
  I63.239 Cerebral infarction due to unspecified occlusion or 
stenosis of unspecified carotid arteries 
  I63.29 Cerebral infarction due to unspecified occlusion or 
stenosis of other precerebral arteries 
  I63.30 Cerebral infarction due to thrombosis of 
unspecified cerebral artery 
  I63.311 Cerebral infarction due to thrombosis of right 
middle cerebral artery 
  I63.312 Cerebral infarction due to thrombosis of left 
middle cerebral artery 
  I63.313 Cerebral infarction due to thrombosis of bilateral 
middle cerebral arteries 
  I63.319 Cerebral infarction due to thrombosis of 
unspecified middle cerebral artery 
  I63.321 Cerebral infarction due to thrombosis of right 
anterior cerebral artery 
  I63.322 Cerebral infarction due to thrombosis of left 
anterior cerebral artery 
  I63.323 Cerebral infarction due to thrombosis of bilateral 
anterior arteries 
  I63.329 Cerebral infarction due to thrombosis of 
unspecified anterior cerebral artery 
  I63.331 Cerebral infarction due to thrombosis of right 
posterior cerebral artery 
  I63.332 Cerebral infarction due to thrombosis of left 
posterior cerebral artery 
  I63.333 Cerebral infarction to thrombosis of bilateral 
posterior arteries 
  I63.339 Cerebral infarction due to thrombosis of 
unspecified posterior cerebral artery 
  I63.341 Cerebral infarction due to thrombosis of right 
cerebellar artery 
  I63.342 Cerebral infarction due to thrombosis of left 
cerebellar artery 




  I63.349 Cerebral infarction due to thrombosis of 
unspecified cerebellar artery 
  I63.39 Cerebral infarction due to thrombosis of other 
cerebral artery 
  I63.40 Cerebral infarction due to embolism of 
unspecified cerebral artery 
  I63.411 Cerebral infarction due to embolism of right 
middle cerebral artery 
  I63.412 Cerebral infarction due to embolism of left middle 
cerebral artery 
  I63.413 Cerebral infarction due to embolism of bilateral 
middle cerebral arteries 
  I63.419 Cerebral infarction due to embolism of 
unspecified middle cerebral artery 
  I63.421 Cerebral infarction due to embolism of right 
anterior cerebral artery 
  I63.422 Cerebral infarction due to embolism of left 
anterior cerebral artery 
  I63.423 Cerebral infarction due to embolism of bilateral 
anterior cerebral arteries 
  I63.429 Cerebral infarction due to embolism of 
unspecified anterior cerebral artery 
  I63.431 Cerebral infarction due to embolism of right 
posterior cerebral artery 
  I63.432 Cerebral infarction due to embolism of left 
posterior cerebral artery 
  I63.433 Cerebral infarction due to embolism of bilateral 
posterior cerebral arteries 
  I63.439 Cerebral infarction due to embolism of 
unspecified posterior cerebral artery 
  I63.441 Cerebral infarction due to embolism of right 
cerebellar artery 
  I63.442 Cerebral infarction due to embolism of left 
cerebellar artery 
  I63.443 Cerebral infarction due to embolism of bilateral 
cerebellar arteries 
  I63.449 Cerebral infarction due to embolism of 
unspecified cerebellar artery 
  I63.49 Cerebral infarction due to embolism of other 
cerebral artery 
  I63.50 Cerebral infarction due to unspecified occlusion or 
stenosis of unspecified cerebral artery 
  I63.511 Cerebral infarction due to unspecified occlusion or 
stenosis of right middle cerebral artery 
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  I63.512 Cerebral infarction due to unspecified occlusion or 
stenosis of left middle cerebral artery 
  I63.513 Cerebral infarction due to unspecified occlusion or 
stenosis of bilateral middle arteries 
  I63.519 Cerebral infarction due to unspecified occlusion or 
stenosis of unspecified middle cerebral art 
  I63.521 Cerebral infarction due to unspecified occlusion or 
stenosis of right anterior cerebral artery 
  I63.522 Cerebral infarction due to unspecified occlusion or 
stenosis of left anterior cerebral artery 
  I63.523 Cerebral infarction due to unspecified occlusion or 
stenosis of bilateral anterior arteries 
  I63.529 Cerebral infarction due to unspecified occlusion or 
stenosis of unspecified anterior cerebral a 
  I63.531 Cerebral infarction due to unspecified occlusion or 
stenosis of right posterior cerebral artery 
  I63.532 Cerebral infarction due to unspecified occlusion or 
stenosis of left posterior cerebral artery 
  I63.533 Cerebral infarction due to unspecified occlusion or 
stenosis of bilateral posterior arteries 
  I63.539 Cerebral infarction due to unspecified occlusion or 
stenosis of unspecified posterior cerebral 
  I63.541 Cerebral infarction due to unspecified occlusion or 
stenosis of right cerebellar artery 
  I63.542 Cerebral infarction due to unspecified occlusion or 
stenosis of left cerebellar artery 
  I63.543 Cerebral infarction due to unspecified occlusion or 
stenosis of bilateral cerebellar arteries 
  I63.549 Cerebral infarction due to unspecified occlusion or 
stenosis of unspecified cerebellar artery 
  I63.59 Cerebral infarction due to unspecified occlusion or 
stenosis of other cerebral artery 
  I63.6 Cerebral infarction due to cerebral venous 
thrombosis, nonpyogenic 
  I63.8 Other cerebral infarction 
  I63.81 Other cerebral infarction due to occlusion or 
stenosis of small artery 
  I63.89 Other cerebral infarction 
  I63.9 Cerebral infarction, unspecified 
  I65.01 Occlusion and stenosis of right vertebral artery 
  I65.02 Occlusion and stenosis of left vertebral artery 




  I65.09 Occlusion and stenosis of unspecified vertebral 
artery 
  I65.1 Occlusion and stenosis of basilar artery 
  I65.21 Occlusion and stenosis of right carotid artery 
  I65.22 Occlusion and stenosis of left carotid artery 
  I65.23 Occlusion and stenosis of bilateral carotid arteries 
  I65.29 Occlusion and stenosis of unspecified carotid 
artery 
  I65.8 Occlusion and stenosis of other precerebral 
arteries 
  I65.9 Occlusion and stenosis of unspecified precerebral 
artery 
  I66.01 Occlusion and stenosis of right middle cerebral 
artery 
  I66.02 Occlusion and stenosis of left middle cerebral 
artery 
  I66.03 Occlusion and stenosis of bilateral middle cerebral 
arteries 
  I66.09 Occlusion and stenosis of unspecified middle 
cerebral artery 
  I66.11 Occlusion and stenosis of right anterior cerebral 
artery 
  I66.12 Occlusion and stenosis of left anterior cerebral 
artery 
  I66.13 Occlusion and stenosis of bilateral anterior 
cerebral arteries 
  I66.19 Occlusion and stenosis of unspecified anterior 
cerebral artery 
  I66.21 Occlusion and stenosis of right posterior cerebral 
artery 
  I66.22 Occlusion and stenosis of left posterior cerebral 
artery 
  I66.23 Occlusion and stenosis of bilateral posterior 
cerebral arteries 
  I66.29 Occlusion and stenosis of unspecified posterior 
cerebral artery 
  I66.3 Occlusion and stenosis of cerebellar arteries 
  I66.8 Occlusion and stenosis of other cerebral arteries 
  I66.9 Occlusion and stenosis of unspecified cerebral 
artery 
  I67.0 Dissection of cerebral arteries, nonruptured 
  I67.1 Cerebral aneurysm, nonruptured 
  I67.2 Cerebral atherosclerosis 
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  I67.3 Progressive vascular leukoencephalopathy 
  I67.4 Hypertensive encephalopathy 
  I67.5 Moyamoya disease 
  I67.6 Nonpyogenic thrombosis of intracranial venous 
system 
  I67.7 Cerebral arteritis, not elsewhere classified 
  I67.81 Acute cerebrovascular insufficiency 
  I67.82 Cerebral ischemia 
  I67.83 Posterior reversible encephalopathy syndrome 
  I67.841 Reversible cerebrovascular vasoconstriction 
syndrome 
  I67.848 Other cerebrovascular vasospasm and 
vasoconstriction 
  I67.89 Other cerebrovascular disease 
  I67.9 Cerebrovascular disease, unspecified 
  I68.0 Cerebral amyloid angiopathy 
  I68.2 Cerebral arteritis in other diseases classified 
elsewhere 
  I68.8 Other cerebrovascular disorders in diseases 
classified elsewhere 
  O22.51 Cerebral venous thrombosis in pregnancy 
unspecified trimester 
  O22.52 Cerebral venous thrombosis in pregnancy second 
trimester 
  O22.53 Cerebral venous thrombosis in pregnancy third 
trimester 
  O87.3 Cerebral venous thrombosis in the puerperium 
  I97.810 Intraoperative cerebrovascular infarction during 
cardiac surgery 
  I97.811 Intraoperative cerebrovascular infarction during 
other surgery 
  I97.820 Postprocedural cerebrovascular infarction during 
cardiac surgery 
  I97.821 Postprocedural cerebrovascular infarction during 
other surgery 
  13. Acute Heart Failure / Pulmonary edema 
  
  J81.0 Acute pulmonary edema 
  I50.1 Left ventricular failure 
  I50.20 Unspecified systolic (congestive) heart failure 
  I50.21 Acute systolic (congestive) heart failure 




  I50.30 Unspecified diastolic (congestive) heart failure 
  I50.31 Acute diastolic (congestive) heart failure 
  I50.33 Acute on chronic diastolic (congestive) heart 
failure 
  I50.40 Unspecified combined systolic (congestive) and 
diastolic (congestive) heart failure 
  I50.41 Acute combined systolic (congestive) and 
diastolic (congestive) heart failure 
  I50.43 Acute on chronic combined systolic (congestive) 
and diastolic (congestive) heart failure 
  I50.9 Heart failure, unspecified 
  14. Severe anesthesia complications 
  
  O74.0 Aspiration pneumonitis due to anesthesia during 
labor and delivery 
  O74.1 Other pulmonary complications of anesthesia 
during labor and delivery 
  O74.2 Cardiac complications of anesthesia during labor 
and delivery 
  O74.3 Central nervous system complications of 
anesthesia during labor and delivery 
  O89.01 Aspiration pneumonitis due to anesthesia during 
the puerperium 
  O89.09 Other pulmonary complications of anesthesia 
during the puerperium 
  O89.1 Cardiac complications of anesthesia during the 
puerperium 
  O89.2 Central nervous system complications of 
anesthesia during the puerperium 
  15. Sepsis  
  
  O85 Puerperal sepsis                         
  O86.04 Sepsis following an obstetrical procedure 
  T80.211A Bloodstream infection due to central venous 
catheter, initial encounter 
  T81.4XXA Infection following a procedure, initial encounter 
  T81.44XA Sepsis following a procedure, initial encounter 
  T81.44XD Sepsis following a procedure, subsequent 
encounter 
  T81.44XS Sepsis following a procedure, sequela 
  T81.44 Sepsis following a procedure 
  R65.20 Severe sepsis without septic shock 
  A40.0 Sepsis due to streptococcus, group A 
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  A40.1 Sepsis due to streptococcus, group B 
  A40.3 Sepsis due to Streptococcus pneumoniae 
  A40.8 Other streptococcal sepsis 
  A40.9 Streptococcal sepsis, unspecified 
  A41.01 Sepsis due to Methicillin susceptible 
Staphylococcus aureus 
  A41.02 Sepsis due to Methicillin resistant Staphylococcus 
aureus 
  A41.1 Sepsis due to other specified staphylococcus 
  A41.2 Sepsis due to unspecified staphylococcus 
  A41.3  Sepsis due to Hemophilus influenza 
  A41.4 Sepsis due to anaerobes 
  A41.50  Gram-negative sepsis, unspecified 
  A41.51  Sepsis due to Escherichia coli 
  A41.52 Sepsis due to pseudomonas 
  A41.53  Sepsis due to serratia 
  A41.59 Other gram-negative sepsis 
  A41.81  Sepsis due to Enterococcus 
  A41.89  Other specified sepsis 
  A41.9 Sepsis, unspecified 
  A32.7   Listerial sepsis 
  16. Shock  
  
  O75.1 Shock during or following labor and delivery 
  R57.0 Cardiogenic shock 
  R57.1 Hypovolemic shock 
  R57.8 Other shock 
  R57.9 Shock, unspecified 
  R65.21  Severe sepsis with septic shock 
  T78.2XXA   Anaphylactic shock, unspecified 
  T88.2XXA   Shock due to anesthesia 
  T88.6XXA  Anaphylactic reaction due to adverse effect of 
correct drug or medicament properly administered 
  T81.10XA  Postprocedural shock unspecified, initial 
encounter 
  T81.11XA  Postprocedural cardiogenic shock, initial 
encounter 
  T81.19XA  Other postprocedural shock, initial encounter 
  17. Sickle Cell Disease with Crisis 
  
  D57.00 Hb-SS disease with crisis, unspecified 
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  D57.01 Hb-SS disease with acute chest syndrome 
  D57.02 Hb-SS disease with splenic sequestration 
  D57.211 Sickle-cell/Hb-C disease with acute chest 
syndrome 
  D57.212 Sickle-cell/Hb-C disease with splenic 
sequestration 
  D57.219 Sickle-cell/Hb-C disease with crisis, unspecified 
  D57.411 Sickle-cell thalassemia with acute chest syndrome 
  D57.412 Sickle-cell thalassemia with splenic sequestration 
  D57.419 Sickle-cell thalassemia with crisis, unspecified 
  D57.811 Other sickle-cell disorders with acute chest 
syndrome 
  D57.812 Other sickle-cell disorders with splenic 
sequestration 
  D57.819 Other sickle-cell disorders with crisis, unspecified 
  18. Air and thrombotic embolism 
  
  I26.01 Septic pulmonary embolism with acute cor 
pulmonale 
  I26.02 Saddle embolus of pulmonary artery with acute 
cor pulmonale 
  I26.09 Other pulmonary embolism with acute cor 
pulmonale 
  I26.90   Septic pulmonary embolism without acute cor 
pulmonale 
  I26.92 Saddle embolus of pulmonary artery without acute 
cor pulmonale 
  I26.99 Other pulmonary embolism without acute cor 
pulmonale 
  O88.011 Air embolism in pregnancy, first trimester 
  O88.012 Air embolism in pregnancy, second trimester 
  O88.013 Air embolism in pregnancy, third trimester 
  O88.019 Air embolism in pregnancy, unspecified trimester 
  O88.02 Air embolism in childbirth 
  O88.03 Air embolism in the puerperium 
  O88.211 Thromboembolism in pregnancy, first trimester 
  O88.212 Thromboembolism in pregnancy, second trimester 
  O88.213 Thromboembolism in pregnancy, third trimester 
  O88.219 Thromboembolism in pregnancy, unspecified 
trimester 
  O88.22  Thromboembolism in childbirth 
  O88.23  Thromboembolism in the puerperium 
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  O88.311 Pyemic and septic embolism in pregnancy, first 
trimester 
  O88.312 Pyemic and septic embolism in pregnancy, second 
trimester 
  O88.313 Pyemic and septic embolism in pregnancy, third 
trimester 
  O88.319 Pyemic and septic embolism in pregnancy, 
unspecified trimester 
  O88.32  Pyemic and septic embolism in childbirth 
  O88.33 Pyemic and septic embolism in the puerperium 
  O88.811 Other embolism in pregnancy first trimester 
  O88.812  Other embolism in pregnancy second trimester 
  O88.813  Other embolism in pregnancy third trimester 
  O88.819  Other embolism in pregnancy, unspecified 
trimester 
  O88.82 Other embolism in childbirth 
  O88.83  Other embolism in the puerperium 
PROCEDURE     ICD-10                                    Descriptions 
  19. Blood transfusion 
  
  30230H0 Transfusion of Autologous Whole Blood into 
Peripheral Vein, Open Approach 
  30230K0 Transfusion of Autologous Frozen Plasma into 
Peripheral Vein, Open Approach 
  30230L0 Transfusion of Autologous Fresh Plasma into 
Peripheral Vein, Open Approach 
  30230M0 Transfusion of Autologous Plasma 
Cryoprecipitate into Peripheral Vein, Open 
Approach 
  30230N0 Transfusion of Autologous Red Blood Cells into 
Peripheral Vein, Open Approach 
  30230P0 Transfusion of Autologous Frozen Red Cells into 
Peripheral Vein, Open Approach 
  30230R0 Transfusion of Autologous Platelets into 
Peripheral Vein, Open Approach 
  30230T0 Transfusion of Autologous Fibrinogen into 
Peripheral Vein, Open Approach 
  30230H1 Transfusion of Non-autologous Whole Blood into  
Peripheral Vein, Open Approach 
  30230K1 Transfusion of Non-autologous Frozen Plasma 
into Peripheral Vein, Open Approach 
  30230L1 Transfusion of Non-autologous  Fresh Plasma into 
Peripheral Vein, Open Approach 
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  30230M1 Transfusion of Non-autologous  Plasma 
Cryoprecipitate into Peripheral Vein, Open 
Approach 
  30230N1 Transfusion of Non-autologous  Red Blood Cells 
into Peripheral Vein, Open Approach 
  30230P1 Transfusion of Non-autologous  Frozen Red Cells 
into Peripheral Vein, Open Approach 
  30230R1 Transfusion of Non-autologous  Platelets into 
Peripheral Vein, Open Approach 
  30230T1 Transfusion of Non-autologous  Fibrinogen into 
Peripheral Vein, Open Approach 
  30233H0 Transfusion of Autologous Whole Blood into 
Peripheral Vein, Percutaneous Approach 
  30233K0 Transfusion of Autologous Frozen Plasma into 
Peripheral Vein, Percutaneous Approach 
  30233L0 Transfusion of Autologous Fresh Plasma into 
Peripheral Vein, Percutaneous Approach 
  30233M0 Transfusion of Autologous Plasma 
Cryoprecipitate into Peripheral Vein, 
Percutaneous Approach 
  30233N0 Transfusion of Autologous Red Blood Cells into 
Peripheral Vein, Percutaneous Approach 
  30233P0 Transfusion of Autologous Frozen Red Cells into 
Peripheral Vein, Percutaneous Approach 
  30233R0 Transfusion of Autologous Platelets into 
Peripheral Vein, Percutaneous Approach 
  30233T0 Transfusion of Autologous Fibrinogen into 
Peripheral Vein, Percutaneous Approach 
  30233H1 Transfusion of Non-autologous Whole Blood into  
Peripheral Vein, Percutaneous Approach 
  30233K1 Transfusion of Non-autologous Frozen Plasma 
into Peripheral Vein, Percutaneous Approach 
  30233L1 Transfusion of Non-autologous  Fresh Plasma into 
Peripheral Vein, Percutaneous Approach 
  30233M1 Transfusion of Non-autologous  Plasma 
Cryoprecipitate into Peripheral Vein, 
Percutaneous Approach 
  30233N1 Transfusion of Non-autologous  Red Blood Cells 
into Peripheral Vein, Percutaneous Approach 
  30233P1 Transfusion of Non-autologous  Frozen Red Cells 
into Peripheral Vein, Percutaneous Approach 
  30233R1 Transfusion of Non-autologous  Platelets into 
Peripheral Vein, Percutaneous Approach 
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  30233T1 Transfusion of Non-autologous  Fibrinogen into 
Peripheral Vein, Percutaneous Approach 
  30240H0 Transfusion of Autologous Whole Blood into 
Central Vein, Open Approach 
  30240K0 Transfusion of Autologous Frozen Plasma into 
Central Vein, Open Approach 
  30240L0 Transfusion of Autologous Fresh Plasma into 
Central Vein, Open Approach 
  30240M0 Transfusion of Autologous Plasma 
Cryoprecipitate into Central Vein, Open Approach 
  30240N0 Transfusion of Autologous Red Blood Cells into 
CentralVein, Open Approach 
  30240P0 Transfusion of Autologous Frozen Red Cells into 
Central Vein, Open Approach 
  30240R0 Transfusion of Autologous Platelets into Central 
Vein, Open Approach 
  30240T0 Transfusion of Autologous Fibrinogen into 
Central Vein, Open Approach 
  30240H1 Transfusion of Non-autologous Whole Blood into  
Central Vein, Open Approach 
  30240K1 Transfusion of Non-autologous Frozen Plasma 
into Central Vein, Open Approach 
  30240L1 Transfusion of Non-autologous  Fresh Plasma into 
Central Vein, Open Approach 
  30240M1 Transfusion of Non-autologous  Plasma 
Cryoprecipitate into Central Vein, Open Approach 
  30240N1 Transfusion of Non-autologous  Red Blood Cells 
into Central Vein, Open Approach 
  30240P1 Transfusion of Non-autologous  Frozen Red Cells 
into Central Vein, Open Approach 
  30240R1 Transfusion of Non-autologous  Platelets into 
Central Vein, Open Approach 
  30240T1 Transfusion of Non-autologous  Fibrinogen into 
Central Vein, Open Approach 
  30243H0 Transfusion of Autologous Whole Blood into 
Central Vein, Percutaneous Approach 
  30243K0 Transfusion of Autologous Frozen Plasma into 
Central Vein, Percutaneous Approach 
  30243L0 Transfusion of Autologous Fresh Plasma into 
Central Vein, Percutaneous Approach 
  30243M0 Transfusion of Autologous Plasma 




  30243N0 Transfusion of Autologous Red Blood Cells into 
Central Vein, Percutaneous Approach 
  30243P0 Transfusion of Autologous Frozen Red Cells into 
Central Vein, Percutaneous Approach 
  30243R0 Transfusion of Autologous Platelets into Centrall 
Vein, Percutaneous Approach 
  30243T0 Transfusion of Autologous Fibrinogen into 
Central Vein, Percutaneous Approach 
  30243H1 Transfusion of Non-autologous Whole Blood into 
Central Vein, Percutaneous Approach 
  30243K1 Transfusion of Non-autologous Frozen Plasma 
into Central Vein, Percutaneous Approach 
  30243L1 Transfusion of Non-autologous  Fresh Plasma into 
Central Vein, Percutaneous Approach 
  30243M1 Transfusion of Non-autologous  Plasma 
Cryoprecipitate into Central Vein, Percutaneous 
Approach 
  30243N1 Transfusion of Non-autologous  Red Blood Cells 
into Central Vein, Percutaneous Approach 
  30243P1 Transfusion of Non-autologous  Frozen Red Cells 
into Central Vein, Percutaneous Approach 
  30243R1 Transfusion of Non-autologous  Platelets into 
Central Vein, Percutaneous Approach 
  30243T1 Transfusion of Non-autologous  Fibrinogen into 
Central Vein, Percutaneous Approach 
  30250H0 Transfusion of Autologous Whole Blood into 
Peripheral Artery, Open Approach 
  30250K0 Transfusion of Autologous Frozen Plasma into 
Peripheral Artery, Open Approach 
  30250L0 Transfusion of Autologous Fresh Plasma into 
Peripheral Artery, Open Approach 
  30250M0 Transfusion of Autologous Plasma 
Cryoprecipitate into Artery Vein, Open Approach 
  30250N0 Transfusion of Autologous Red Blood Cells into 
Artery Vein, Open Approach 
  30250P0 Transfusion of Autologous Frozen Red Cells into 
Artery Vein, Open Approach 
  30250R0 Transfusion of Autologous Platelets into Artery 
Vein, Open Approach 
  30250T0 Transfusion of Autologous Fibrinogen into Artery 
Vein, Open Approach 
  30250H1 Transfusion of Non-autologous Whole Blood into  
Peripheral Artery, Open Approach 
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  30250K1 Transfusion of Non-autologous Frozen Plasma 
into Peripheral Artery, Open Approach 
  30250L1 Transfusion of Non-autologous  Fresh Plasma into 
PeripheralArtery, Open Approach 
  30250M1 Transfusion of Non-autologous  Plasma 
Cryoprecipitate into Peripheral Artery, Open 
Approach 
  30250N1 Transfusion of Non-autologous  Red Blood Cells 
into Peripheral Artery, Open Approach 
  30250P1 Transfusion of Non-autologous  Frozen Red Cells 
into Peripheral Artery, Open Approach 
  30250R1 Transfusion of Non-autologous  Platelets into 
Peripheral Artery, Open Approach 
  30250T1 Transfusion of Non-autologous  Fibrinogen into 
Peripheral Artery, Open Approach 
  30253H0 Transfusion of Autologous Whole Blood into 
Peripheral Vein, Percutaneous Approach 
  30253K0 Transfusion of Autologous Frozen Plasma into 
Peripheral Artery, Percutaneous Approach 
  30253L0 Transfusion of Autologous Fresh Plasma into 
Peripheral Artery, Percutaneous Approach 
  30253M0 Transfusion of Autologous Plasma 
Cryoprecipitate into Peripheral Artery, 
Percutaneous Approach 
  30253N0 Transfusion of Autologous Red Blood Cells into 
PeripheralArtery, Percutaneous Approach 
  30253P0 Transfusion of Autologous Frozen Red Cells into 
Peripheral Artery, Percutaneous Approach 
  30253R0 Transfusion of Autologous Platelets into 
Peripheral Artery, Percutaneous Approach 
  30253T0 Transfusion of Autologous Fibrinogen into 
Peripheral Artery, Percutaneous Approach 
  30253H1 Transfusion of Non-autologous Whole Blood into  
Peripheral Artery, Percutaneous Approach 
  30253K1 Transfusion of Non-autologous Frozen Plasma 
into Peripheral Artery, Percutaneous Approach 
  30253L1 Transfusion of Non-autologous  Fresh Plasma into 
Peripheral Artery, Percutaneous Approach 
  30253M1 Transfusion of Non-autologous  Plasma 
Cryoprecipitate into Peripheral Artery, 
Percutaneous Approach 
  30253N1 Transfusion of Non-autologous  Red Blood Cells 
into Peripheral Artery, Percutaneous Approach 
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  30253P1 Transfusion of Non-autologous  Frozen Red Cells 
into Peripheral Artery, Percutaneous Approach 
  30253R1 Transfusion of Non-autologous  Platelets into 
Peripheral Artery, Percutaneous Approach 
  30253T1 Transfusion of Non-autologous  Fibrinogen into 
Peripheral Artery, Percutaneous Approach 
  30260H0 Transfusion of Autologous Whole Blood into 
Central  Artery, Open Approach 
  30260K0 Transfusion of Autologous Frozen Plasma into 
Central  Artery, Open Approach 
  30260L0 Transfusion of Autologous Fresh Plasma into 
Central  Artery, Open Approach 
  30260M0 Transfusion of Autologous Plasma 
Cryoprecipitate into Central  Artery, Open 
Approach 
  30260N0 Transfusion of Autologous Red Blood Cells into 
Central  Artery, Open Approach 
  30260P0 Transfusion of Autologous Frozen Red Cells into 
Central  Artery, Open Approach 
  30260R0 Transfusion of Autologous Platelets into Central  
Artery, Open Approach 
  30260T0 Transfusion of Autologous Fibrinogen into 
Central  Artery, Open Approach 
  30260H1 Transfusion of Non-autologous Whole Blood into  
Central  Artery, Open Approach 
  30260K1 Transfusion of Non-autologous Frozen Plasma 
into Central  Artery, Open Approach 
  30260L1 Transfusion of Non-autologous  Fresh Plasma into 
Central  Artery, Open Approach 
  30260M1 Transfusion of Non-autologous  Plasma 
Cryoprecipitate into Central  Artery, Open 
Approach 
  30260N1 Transfusion of Non-autologous  Red Blood Cells 
into Central  Artery, Open Approach 
  30260P1 Transfusion of Non-autologous  Frozen Red Cells 
into Central Artery, Open Approach 
  30260R1 Transfusion of Non-autologous  Platelets into 
Central  Artery, Open Approach 
  30260T1 Transfusion of Non-autologous  Fibrinogen into 
Central  Artery, Open Approach 
  30263H0 Transfusion of Autologous Whole Blood into 
Central Artery, Percutaneous Approach 
  30263K0 Transfusion of Autologous Frozen Plasma into 
Central Artery, Percutaneous Approach 
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  30263L0 Transfusion of Autologous Fresh Plasma into 
Central Artery, Percutaneous Approach 
  30263M0 Transfusion of Autologous Plasma 
Cryoprecipitate into Central Artery, Percutaneous 
Approach 
  30263N0 Transfusion of Autologous Red Blood Cells into 
Central Artery, Percutaneous Approach 
  30263P0 Transfusion of Autologous Frozen Red Cells into 
Central Artery, Percutaneous Approach 
  30263R0 Transfusion of Autologous Platelets into Centrall 
Artery, Percutaneous Approach 
  30263T0 Transfusion of Autologous Fibrinogen into 
Central Artery, Percutaneous Approach 
  30263H1 Transfusion of Non-autologous Whole Blood into 
Central Artery, Percutaneous Approach 
  30263K1 Transfusion of Non-autologous Frozen Plasma 
into Central Artery, Percutaneous Approach 
  30263L1 Transfusion of Non-autologous  Fresh Plasma into 
Central Artery, Percutaneous Approach 
  30263M1 Transfusion of Non-autologous  Plasma 
Cryoprecipitate into Central Artery, Percutaneous 
Approach 
  30263N1 Transfusion of Non-autologous  Red Blood Cells 
into Central Artery, Percutaneous Approach 
  30263P1 Transfusion of Non-autologous  Frozen Red Cells 
into Central Artery Percutaneous Approach 
  30263R1 Transfusion of Non-autologous  Platelets into 
Central Artery, Percutaneous Approach 
  30263T1 Transfusion of Non-autologous  Fibrinogen into 
Central Artery, Percutaneous Approach 
  20. Cardio monitoring  
  Not carried forward (either very low frequency or imprecise usage) 
  21. Conversion of cardiac rhythm  
  5A2204Z Restoration of Cardiac Rhythm, Single 
Cardiac countershock with successful conversion 
to sinus rhythm ICD-9: 99.61,2,4,9  
  5A12012 Performance of Cardiac Output, Single, Manual  
  22. Hysterectomy   
  0UT90ZZ  Resection of Uterus, Open Approach 
  0UT94ZZ Resection of Uterus, Percutaneous Endoscopic 
Approach 




  0UT98ZZ  Resection of Uterus, Via Natural or Artificial 
Opening Endoscopic 
  0UT9FZZ  Resection of Uterus, Via Natural or Artificial 
Opening With Percutaneous Endoscopic 
Assistance 
  23. Operations on heart and pericardium 
  Not carried forward (either very low frequency or imprecise usage) 
  24. Temporary tracheostomy  
  0B110Z4 Bypass Trachea to Cutaneous, Open Approach 
  0B110F4 Bypass Trachea to Cutaneous with Tracheostomy 
Device, Open Approach 
  0B113Z4 Bypass Trachea to Cutaneous, Percutaneous 
Approach 
  0B113F4 Bypass Trachea to Cutaneous with Tracheostomy 
Device, Percutaneous Approach 
  0B114Z4 Bypass Trachea to Cutaneous, Percutaneous 
Endoscopic Approach 
  0B114F4 Bypass Trachea to Cutaneous with Tracheostomy 
Device, Percutaneous Endoscopic Approach 




  5A1935Z Respiratory Ventilation, Less than 24 Consecutive 
Hours 
  5A1945Z Respiratory Ventilation, 24-96 Consecutive Hours 
  5A1955Z Respiratory Ventilation, Greater than 96 
Consecutive Hours 
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'O000', 'O001', 'O002', 'O008', 'O009', 
'O010', 'O011', 'O019', 'O020', 'O021', 
'O0281', 'O0289',  
'O029', 'O030', 'O031', 'O032', 'O0330', 
'O0331', 'O0332', 'O0333', 'O0334', 
'O0335', 'O0336', 'O0337', 'O0338',  
'O0339', 'O034', 'O035', 'O036', 'O037', 
'O0380', 'O0381', 'O0382', 'O0383', 
'O0384', 'O0385', 'O0386', 'O0387', 
'O0388', 'O0389', 'O039', 'O045', 'O046', 
'O047', 'O0480', 'O0481', 'O0482', 
'O0483', 'O0484', 'O0485', 
'O0486', 'O0487', 'O0488', 'O0489', 
'O070', 'O071', 'O072', 'O0730', 'O0731', 
'O0732', 'O0733', 'O0734', 
'O0735', 'O0736', 'O0737', 'O0738', 
'O0739', 'O074', 'O080', 'O081', 'O082', 
'O083', 'O084', 'O085', 'O086', 





'10A00ZZ', '10A03ZZ', '10A04ZZ', 




MS-DRG '765', '766', '767', '768', '774', '775' 
Diagnosis codes 'Z370', 'Z371', 'Z372', 'Z373', 'Z374', 
'Z3750', 'Z3751', 'Z3752', 'Z3753', 'Z3754', 
'Z3759', 'Z3760', 'Z3761', 'Z3762', 'Z3763', 
'Z3764', 'Z3769', 'O80', 'O82' 
 
Procedure codes '10D00Z0', '10D00Z1', '10D00Z2', 
'10D07Z3', '10D07Z4', '10D07Z5', 
'10D07Z6', '10D07Z7', '10D07Z8', 
'10E0XZZ' 
